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Abstract 
The Role of pH, Self-Association, and Lipid Binding in Vinculin Tail Structure and Function 
(Under the direction of Dr. Sharon L. Campbell) 
 
 Vinculin is a highly conserved cytoskeletal protein that localized to sites of cell 
adhesion and is involved in linking the actin cytoskeleton to the cell membrane.  Loss of 
normal vinculin function has been associated with cancer phenotypes, cardiovascular disease, 
and lethal errors in embryogenesis.  Vinculin is composed of a 90 kDa head domain (Vh) and 
a 21 kDa tail domain (Vt) connected by a flexible “neck” region.  Vh and Vt form auto-
inhibitory interactions in its inactive state.  Conformational changes in these domains have 
been proposed to be important for vinculin activation, freeing domains to bind to a variety of 
ligands involved in cell adhesion processes.   
My work has focused on the vinculin tail domain.  I have assigned the majority of the 
backbone 1HN, 15N, 13Cα, 13CO, and side chain 13Cβ NMR resonances of Vt (Biological 
Magnetic Resonance Data Bank, accession number 15653).  These assignments have proven 
useful for investigating the effects of ligand binding, pH and Vt self-association. 
The tail domain of vinculin has been reported to undergo a pH dependent 
conformational change between pH 5.5 and 7.5.  However, we found no indication of a 
significant alteration in Vt conformation in this pH range by both circular dichroism and 
NMR.  Although, Vt was reported to self-associate at pH 5.5 while remaining monomeric at 
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pH 7.0, results from analytical ultracentrifugation indicate that Vt self-associates at both pH 
values, albeit with weak affinity (Kd > 100 µM). 
The binding of acidic phospholipids by Vt has been proposed to play a role in 
vinculin activation and focal adhesion turnover.  We observe a marked affinity of Vt for 
phosphatidylinositol 4,5-bisphosphate (PIP2), but no significant binding to 
phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylserine (PS), or 
phosphatidylinositol (PI) in the context of mixed lipid vesicles.  A significant increase in 
PIP2 binding was observed with multiple mutant forms of Vt, expected to alter the 
conformation or flexibility of the N-terminal strap of Vt, suggesting that a rearrangement of 
this N-terminal strap may be required for PIP2 binding.  Additionally, we find that the 
hydrophobic hairpin at the C-terminus of Vt is not critical for lipid insertion, as previously 
proposed. 
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Chapter I. 
Introduction 
 
A.   Vinculin 
Vinculin is a ubiquitously expressed, abundant, and highly conserved 116 kDa 
protein that localizes to membrane-associated complexes and couples the actin cytoskeleton 
to the membrane at sites of cellular attachment.  These sites of attachment include adherence 
junctions and focal adhesions which link cells to neighboring cells and cells to extracellular 
matrix (ECM), respectively[1].  A larger isoform of vinculin, called metavinculin, is found 
exclusively in smooth and cardiac muscle[2].  Both vinculin and metavinculin are found in 
costameres, protein complexes that link the force generating sacromeres to the cell 
membrane, and in cardiac muscle both isoforms are also localized to intercalated discs, a 
specialized linkage between adjacent cells[2, 3].  In all of these locations vinculin plays a 
role in connecting the actin cytoskeleton to the membrane and therefore located at primary 
sites of contractile force transmission.  In addition to the obvious importance for muscle 
contraction, transmission of contractile forces is also critical for cell motility and migration.  
Not too surprising, vinculin plays an important role in processes that require regulated cell 
movement, including development and wound healing, as well as pathological processes 
including invasion and metastasis[4, 5].  Dynamic regulation of cell adhesions and actin 
cytoskeletal morphology is also important for processes involved in cell growth, 
differentiation, and cell death.  Aberrant function or regulation of these processes contributes 
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to a number of human diseases, including cancer.  Loss of normal vinculin function, in 
particular, has been associated with cancer phenotypes, cardiovascular disease, and lethal 
errors in embryogenesis[5-9]. 
 
B.   The Role of Vinculin in Development, Cell Motility, Cell Survival, and Cancer 
 Cell adhesions, whether they are between adjacent cells or with the extracellular 
matrix (ECM), play a critical role in development and survival.  Ordered cellular motility 
requires adhesive structures to be dynamic and precisely controlled.  In addition, these sites 
of adhesion are also involved in the sensing and transduction of a multitude of signals both 
from the extracellular and intracellular environment.  Vinculin plays an important role in the 
regulation and function of both focal adhesion and adherence junctions and, consequently, 
affects many cellular processes that are mediated by cellular attachment.  Vinculin null mice 
die in early embryogenesis, with mice embryos exhibiting brain and heart defects[5].  
Vinculin null cells also exhibit tumor suppressor properties, including: decreased focal 
adhesion, increased motility, resistance to apoptosis and anoikis, ability to grow in soft agar, 
and altered signaling through extracellular signal-regulated kinase (ERK)[4, 5, 7, 10-12].  
Additional support for vinculin’s role in tumor suppression comes from studies showing 
decreased vinculin protein levels that are correlated with highly metastatic, invasive cancers.  
Moreover, transfection of vinculin cDNA into tumor cells lines with decreased vinculin 
expression drastically reduces their tumorigenic ability[13], further solidifying vinculin’s role 
as a tumor suppressor.      
 
C.   The Role of Vinculin in Cardiovascular Function 
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 Although vinculin is a widely expressed protein, it is particularly abundant in muscle 
cells where it localizes to costameres, which link sacromeres to the cell membrane[3].  In 
contrast, a larger isoform of vinculin, metavinculin, is exclusively expressed in smooth and 
cardiac muscle and contains a 68 amino acid insertion in the tail domain[2, 14, 15].  Both 
isoforms are found in intercalated discs of cardiac tissue[2].  Although no ligand specific to 
the metavinculin insert has been found, there is some evidence suggesting that metavinculin 
possesses distinct properties.  In addition to the tissue specific expression, metavinculin tail 
(MVt) promotes distinct F-actin organization from the vinculin tail domain (Vt).  Both Vt 
and MVt bind F-actin, however Vt bundles F-actin into parallel filaments, while MVt 
generates “highly viscous F-actin webs”[15]. 
Vinculin null mice and nematodes both die in development with cardiac and muscle 
defects, respectively[5, 16].  While it is possible that these developmental abnormalities are 
due solely to defects in cell migration, it is also possible that vinculin has a specific 
developmental role in these tissues.  Regardless of its role in development, both vinculin and 
metavinculin have been implicated in cardiovascular function, as separate mutations in each 
have been associated with human cardiomyopathy.  A leucine to methionine mutation at 
position 277 in vinculin is believed to confer susceptibility to hypertrophic cardiomyopathy, 
while an arginine to tryptophan substitution at position 975 in metavinculin is associated with 
both hypertrophic and dilated cardiomyopathy[17, 18].  The metavinculin mutation (R975W) 
has also been shown to alter F-actin organization in vitro as cardiac myocyte samples 
containing the mutation have irregular and fragmented intercalated discs (structures involved 
in transmitting contractile force between cardiac myocytes)[19].  Even in the absence of 
mutations, samples taken from patients with obstructive hypertrophic cardiomyopathy and 
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aortic stenosis, show a consistent defect in vinculin/metavinculin expression in intercalated 
discs suggesting an important and distinct role for vinculin/metavinculin in cardiac tissue[8].   
 
D.   Vinculin Domains and Their Ligands 
Early studies using electron microscopy and proteolytic cleavage approaches 
indicated that vinculin consists of three domains; a globular head domain (Vh), a flexible 
neck, and a tail domain (Vt)[20, 21].  Each of these domains has been shown to bind multiple 
ligands.  The head domain has been shown to interact with talin, α-actinin, α-catenin, β-
catenin, and the bacterial virulence factor IpaA.  The neck domain interacts with vinexin, 
ponsin, the Arp 2/3 complex, and the vasodilator-stimulated phosphoprotein (VASP).  The 
tail domain binds to F-actin, paxillin, protein kinase C-α (PKCα), acidic phospholipids and 
α-synemin (reviewed by Ziegler, et al.,  2006)[22, 23]. 
 
E.   Vinculin Structure and Auto-inhibition 
Multiple crystal structures of vinculin have been solved, including the full length 
protein, isolated domains, and isolated domains in complex with ligands[24-29].  The full 
length crystal structure was published in 2004, showing that vinculin consists of a “bundle of 
bundles”[24].  The structure is comprised of 8 helical bundles that are organized into tandem 
pairs.  Each of the first three tandem pairs (D1-D3) contains two four-helix bundles with one 
long helix connecting them.  The fourth tandem pair contains two helical bundles (D4 and 
Vt) connected by a flexible linker.  The head domain of vinculin (Vh) consists of D1-D3 
which forms a clamp-like structure, with the tail domain (Vt) held in its center (Figure 1.1).  
Vt consists of a five-helix bundle fold.  The isolated domain shows similar structural features 
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to Vt in the context of full length vinculin[24, 25].  Multiple sites of interaction between Vh 
and Vt occur, giving rise to a compact, auto-inhibitory complex.  While the majority of 
contacts are observed between D1 and Vt, additional interactions occur between Vt and D3 
and D4.  The numerous interactions between Vh and Vt, give rise to a high affinity 
intramolecular interaction, with an estimated Kd of ~1 nM [24].  Activation of vinculin 
requires release of auto-inhibitory Vh and Vt interactions to expose binding sites for 
interactions with  α-actinin, VASP, talin, F-actin, PKCα, acidic phospholipids, and the 
Arp2/3 complex[10, 30-35]. 
 
F.   Vinculin Activation 
 The tight auto-inhibitory interaction between the head and tail domains of vinculin is 
possible due to three distinct interaction surfaces between Vh and Vt (D1-Vt, D3-Vt, D4-
Vt)[24, 36].  The apparent affinity is further increased due to the intramolecular nature of the 
interaction (once separated Vt does not diffuse away from Vh).  Notably, binding cell 
adhesion protein, talin, to the vinculin head domain has been proposed to disrupt auto-
inhibitory Vh-Vt interactions to activate vinculin.   However, a detailed characterization 
study of talin/Vh interactions, indicated that although  talin can efficiently displace Vt from 
the isolated D1 fragment of Vh[29], talin binding alone, disrupts only a subset of interactions 
between Vt and Vh, and thus cannot release auto-inhibitory interactions in the context of the 
full length protein[36].  To date, no single native ligand has been found with sufficient 
affinity to compete with the Vh-Vt interaction, suggesting a combination of multiple ligands 
are needed to activate vinculin[37].  A combinatorial activation mechanism is supported by 
the ability of talin to successfully interact with full length vinculin in the presence of 
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actin[37].  Given the number of ligands that bind to both the head and tail domains of 
vinculin, it is possible that additional ligand pairs may also be capable of activating vinculin 
or that subsequent binding of additional ligands after activation could help maintain vinculin 
in an activated state.  Additional ligands interacting with the head, neck, or tail could 
conceivably play such roles.  Interestingly the Shigella flexneri virulence factor, IpaA, 
appears to activate vinculin in the absence of other ligands[37].  Although IpaA contains two 
vinculin-binding sites (VBS), their binding to vinculin is mutually exclusive.  Crystal 
structures of D1 of vinculin with either IpaA VBS have been solved and appear to mimic the 
binding of vinculin-binding sites from talin and α-actinin[28].  IpaA-VBS has been reported 
to have at least 10-fold higher affinity for Vh-D1 relative to other VBSs, which may account 
for its ability to activate vinculin[28].  However, it cannot be ruled out that an additional 
interaction between IpaA and vinculin could be involved in disrupting the Vt-D3 and Vt-D4 
interactions. 
 
G.   The Tail Domain of Vinculin and its Ligands 
1.   Vinculin Tail Structure 
 The crystal structure of Vt (residues 879-1066) was published in 1999, showing a 
bundle of five amphipathic helices[25].  The conformation of the isolated tail domain, solved 
at pH 5.5, is virtually identical to that seen in the auto-inhibited full length structure of 
vinculin, solved at pH 6.5 in 2004[24].  In the full length structure of vinculin, Vt is held by 
the clamp-like Vh.  In the isolated crystal structure, however, the asymmetric unit contains 
two Vt molecules, forming a dimer with a hydrophobic interaction interface covering end of 
helix 4 and the beginning of helix 5.  Some of this same interface is involved in the 
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interaction between Vt and the D1 domain of Vh in the auto-inhibited structure[24].  In 
addition to the main helical bundle of Vt, there are two structural features of interest; an N-
terminal strap and C-terminal extension (Figure 1.2).   
 Residues 879-893 form the N-terminal strap, and adopt an extended conformation.  In 
the crystal structure of the isolated tail domain, this strap is seen in multiple conformations, 
suggesting some conformational mobility.  In the more ordered conformation, this N-
terminal strap packs against helix 1 and 2.  In the second conformation, only weak electron 
density was seen prior to residue 890, and crystal contacts were seen at the position the strap 
occupied in the first conformation.  Due to a more ordered electron density and the lack of 
crystal contacts, the conformation with the strap packing against helix 1 and 2 was assumed 
to be a better model of the structure in solution[25].  In support of this idea, in the full length 
vinculin structure the N-terminal strap of Vt is seen in a very similar conformation, packed 
along helix 1 and 2.  Residues F885 and D882 of the strap form interactions with the helix 
bundle, and are likely important to maintaining the extended conformation along the helix 1-
2 interface.  In both the isolated tail structure and the full length vinculin structure, the side 
chain of F885 packs in a hydrophobic crevice between helix 1 and 2, making interaction with 
H906 of helix 1.  Interactions made by D882 vary some between crystal structures, but they 
include interactions with S914 and K924, located in the helix 1-2 loop and helix 2 
respectively, and K1061 and Y1065, located in the C-terminal extension[24, 25]. 
 The C-terminal extension of Vt consists of residues 1047-1066 and is located at the 
bottom of the helical bundle.  Residues in this C-terminal extension form the bottom of the 
hydrophobic core, packing against helix 1, the helix 1-2 loop, and helix 5.  In particular, 
L1056 inserts into a hydrophobic cavity while W1058 packs against W912 of the helix 1-2 
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loop and these interactions are thought to be important for the structural stability of Vt[25, 
38].  The final C-terminal residues form a “hydrophobic hairpin” (TPWYQ) that emerges 
close to the N-terminal strap.  It has been postulated that this hydrophobic hairpin is 
important for insertion into the membrane. 
 The crystal structure of Vt also aided in identifying two solvent-accessible surface 
features that have been postulated to be important for lipid binding; the “basic collar” and 
“basic ladder” (Figure 1.2)[25].  The basic collar consists of residues from helix 1, helix 5, 
and the C-terminal extension, including R910, K911, R1039, K1049, R1060, and K1061.  
These residues surround the hydrophobic hairpin, at the bottom of the helical bundle.  The 
basic ladder consists of residues located along the length of helix 3 and at the base of the 
helical bundle, including K944, R945, K952, K956, R963, K966, K970, R978, R1008, and 
R1049. 
 
2.   Actin Interactions 
 The binding of actin is considered one of the primary functional consequences of 
vinculin activation.  Indeed, despite findings that vinculin can interact with additional actin-
binding proteins (i.e., Arp2/3, Vasp, etc), interactions between the vinculin tail domain and 
actin, provide a major link between focal adhesions and the actin cytoskeleton [39].  In 
addition to F-actin binding, vinculin also promotes cross-linking of actin bundles[40].  F-
actin binding has been reported to induce Vt dimerization with dimerization important for 
Vt-induced F-actin bundling[41].  Binding of F-actin by Vt is blocked by the auto-inhibitory 
Vh-Vt interaction and full length vinculin neither binds or crosslinks F-actin in the absence 
additional ligands[32, 37].  Two isolated recombinant fragments of Vt were shown to bind to 
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F-actin[42], however, in the context of the crystal structure of Vt neither of these fragments 
correspond to a canonical actin binding site.  Changes in protease sensitivity and tryptophan 
fluorescence upon F-actin association have been reported, providing evidence of a possible 
conformational change in Vt upon actin binding[25], further complicating clear identification 
of the binding site or sites. 
Three-dimensional models of Vt, both bound to and crosslinking F-actin, were 
created using a combination of electron microscopy, image analysis and computational 
docking[43].  Crystal structures of Vt, alone and in the context of full length vinculin, were 
docked into 3D difference maps produced from images of F-actin decorated with Vt.  
However, in contrast to earlier observations[25], the docked protein models did not support a 
large scale conformational change in Vt upon binding F-actin, as a  high correlation of the 
docked structure with the corresponding reconstructions was obtained with no major clashes 
observed between the docked proteins [43].  This model supports Vt binding to two separate 
actin monomers along the actin filament via two distinct sites.  The upper interaction 
interface includes residues at the top of helices 2 and 3, along with residues contained in the 
N-terminal strap (883-890).  The corresponding interface on actin is located at the bottom of 
subdomain 1, and contains a large hydrophobic pocket implicated in interactions with several 
actin binding proteins[43].  The lower F-actin/Vt interaction interface is more polar, is 
located at the base of helix 3, and includes residues close to the C-terminus.  This Vt 
interface interacts with an acidic region at the top of subdomain 1 of a second actin 
monomer.  Superimposition of the full length structure of vinculin with the tail domain in the 
actin bound model exhibits severe clashes between Vh and actin, consistent with the 
evidence that the Vh-Vt interaction must be released to facilitate actin binding[32, 43].  A 
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three-dimensional model of actin bundling by Vt was produced by computationally docking 
the F-actin-Vt model into tomographic reconstructions of Vt-crosslinked actin arrays.  This 
model shows an asymmetric dimer with the C-terminal residues of one monomer (located at 
the bottom of the helical bundle) contacting the N-terminal strap along the side of the second 
monomer.  However, as severe steric clashes are observed between the C-terminus of one 
monomer and the N-terminus of the other, it was speculated that either one or both of these 
regions of Vt may undergo a conformational change to promote F-actin bundling[43].  The 
overall 5-helix bundle of Vt is believed to remain largely unaltered by either F-actin binding 
or bundling.  Currently, no specific point mutations in Vt have been identified that effectively 
block its F-actin binding and/or bundling activity.  The production and characterization of 
such mutants would be beneficial in elucidating the activation, role, and function of vinculin 
in vivo. 
 
3.   Lipid Interactions 
 The tail domain of vinculin has been shown by multiple groups to bind acidic 
phospholipids[25, 31, 44, 45].  Among the various types of acidic phospholipids, Vt has been 
shown to have an increased affinity for phosphatidylinositol 4,5-bisphosphate (PIP2), 
although the affinity and degree of specificity has varied in the literature (possibly due to 
varying methods used to assay binding)[24, 25, 31, 46, 47].  PIP2 has been shown to be a key 
regulator of actin dynamics, adhesion-site turnover, and cell morphology[48, 49], and 
therefore is of particular interest as its interaction with Vt could explain some of vinculin’s 
effects on cell motility and morphology.  The interaction between Vt and lipids alters 
vinculin interaction with actin, talin, and PKCα.  Moreover, in earlier studies, lipid binding 
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to vinculin was proposed to release interactions between Vh and Vt, thereby leading to 
vinculin activation[24, 31, 35, 46, 50].  However, subsequent work indicated that 
phospholipid binding to full length vinculin is significantly reduced relative to Vt, and that 
this interaction is unable release Vh-Vt interaction.  Thus, phospholipid binding to vinculin, 
alone, does not lead to vinculin activation[31, 44].  Instead of a role of phospholipids in 
vinculin activation and localization to sites of adhesion, multiple reports have now suggested 
that vinculin-lipid interactions are important in regulating focal adhesion disassembly and 
turnover, a process critical to cell motility[38, 44]. 
 Although the lipid binding to vinculin resides in the tail domain, multiple disparate 
sites have been proposed.  Deletion mutagenesis, using a Vt fragment containing residues 
916-970, suggested a binding site localized to helix 3 and 4[31].  However, as this fragment, 
comprised of helix 3 and 4, is markedly amphipathic and undergoes self-association, the 
isolated fragment may possess different (perhaps non-specific) phospholipid interactions.  
Once a structure of Vt became available, additional sites of possible lipid interaction were 
proposed.  The C-terminus was postulated to be important for insertion into the lipid 
membrane, based on results obtained from a deletion mutant (Vt∆C) lacking residues 1052-
1066 that showed a significant decrease in lipid binding.  Additionally, a “basic collar” and 
“basic ladder” were noted as possible sites of electrostatic interaction with the phospholipid 
headgroup[25].  The “basic collar” surrounds the C-terminal extension and includes residues 
from the bottom of helices 1 and 5 and within the C-terminus.  The “basic ladder” contains a 
stretch of exposed basic residues covering the length of helix 3.  A model for phospholipid 
binding to Vt was proposed by Liddington and co-workers, in which following insertion of 
the C-terminus, the helical bundle “unfurls” exposing helical hairpins which could interact 
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with the lipid membrane and possibly additional ligands[25].  Further research, however, 
indicated that deletion of 15 C-terminal residues in Vt, significantly destabilizes the Vt 
tertiary fold due to removal of a hydrophobic interactions between the C-terminus and the 
base of the helical bundle.  Hence, the reduction in lipid binding to Vt∆C is likely to result 
from large scale conformational/dynamic  change in Vt[38].  Two remaining basic collar 
residues, K911 and K924 were also proposed as key determinants of PIP2 binding [24, 38].  
A separate study produced a “lipid binding deficient” variant of vinculin by introducing a 
series of mutations into the basic collar and basic ladder; mutation of 4 basic residues (K952, 
K956, R963, and K966) in the basic ladder and 2 residues (R1060 K1016) within the basic 
collar and contained in the C-terminal extension.  Mutation of either group of residues alone 
led to only a partial loss in lipid binding[44].  However, the effects of these multiple 
mutations on ligand binding were not fully characterization.  Moreover, no studies were 
conducted to determine whether mutations of 6 residues within Vt alters Vt structure.  Given 
the 3D disposition of the basic ladder and collar, it is unlikely that vinculin binds both sites, 
unless more than one site of interaction occurs upon interaction with phospholipids.  Hence, 
with multiple mutations in disparate surfaces of the protein, the complete picture of lipid 
binding remains unclear.  It is also still unknown whether these mutations have effected the 
conformation of Vt causing confusion in data interpretation, as appears to have happened 
with Vt∆C. 
 
4.   Paxillin Interactions  
 Paxillin is a 68 kDa cytoskeletal protein that is associated with focal adhesions and 
exhibits increased tyrosine phosphorylation following cell adhesion or transformation by the 
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Rous sarcoma virus[51, 52].  Paxillin was identified as a vinculin binding protein that 
associates with a C-terminal cleavage fragment of vinculin containing the tail domain[51].  
The domain structure of paxillin consists of 5 leucine-rich ‘LD’ motifs and 4 double zinc 
finger LIM domains.  Paxillin is believed to function as a molecular scaffold, with both the 
LD and LIM domains participating in protein-protein interactions [53, 54].  Three of the LD 
motifs, LD1, LD2, and LD4, were shown to bind to the tail domain of vinculin[55].  Deletion 
mutagenesis studies suggested that paxillin binds to a Vt fragment comprising residues 979-
1000[56].  Paxillin binding was assessed by an ‘overlay’ assay, by first using denaturing 
SDS-gel electrophoresis of Vt or Vt fragments, followed by blotting on nitrocellulose filters 
prior to paxillin binding[25, 56].  It should be noted that this fragment contains the majority 
of helix 4 of Vt, which is markedly amphipathic.  Thus, the conformation of this fragment in 
overlay binding assays could be significantly different from Vt in solution. 
 The physiological role of the vinculin-paxillin interaction is currently unclear.  
Intriguingly, both vinculin and focal adhesion kinase (FAK) bind to the LD2 and LD4 
domains of paxillin, suggesting that both of these cell adhesion proteins may compete for 
paxillin binding.  This idea is further supported by findings that  alterations in vinculin 
expression can modulate FAK-paxillin interactions and the activity of extracellular signal-
regulated kinase (ERK), leading to changes in cell motility and survival[7].  However, no 
clear in vivo evidence currently exists, that supports a direct interaction between vinculin and 
paxillin, due at least in part to a lack of characterized, specific mutations to block the 
interaction.  Further complicating this matter, recent evidence indicates that vinculin 
overexpression induces the robust recruitment of paxillin to focal adhesions, and this 
recruitment occurs independent of the vinculin tail domain[39].  Although care must be taken 
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in the interpretation of protein overexpression experiments, this would appear to suggest that, 
in addition to possible direct interactions with Vt, vinculin either possesses additional 
paxillin interactions or vinculin is capable of modulating the subcellular localization of 
paxillin indirectly.  As there is no evidence suggesting a secondary paxillin binding site, the 
latter appears more likely.  However, either circumstance may complicate interpretation of 
data concerning the physiological role of a vinculin-paxillin interaction. 
 
5.   Vinculin Tail Phosphorylation 
 Vinculin is phosphorylated as a result of various stimuli, including calcium, phorbol 
esters, and leukotriene D(4)[57-59].  In the case of calcium stimulation, phosphorylation of 
vinculin is observed in connection with both platelet stimulation and formation of tight 
junctions[59, 60].  Src kinases and protein kinase C-α (PKCα) are both capable of 
phosphorylating vinculin, although a direct functional role for phosphorylation by either 
kinase is still not understood[35, 61-63]. 
During cell spreading, PKCα has been shown to interact with vinculin in vivo via 
crosslinking and pulldown experiments, and two serine residues in Vt, S1033 and S1045, 
have been shown to be phosphorylated by PKCα in vitro.  The in vitro phosphorylation of Vt 
by PKCα was promoted by the addition of acidic phospholipids, leading to the speculation 
that binding of phospholipids may help release of the Vh-Vt complex allowing 
phosporylation[35].   
Two residues phosphorylated by Src have been identified, one in Vh and the other in 
Vt.  The Src phosphorylation site in Vt is the sole tyrosine in the domain, Y1065, which is 
the second to last residue from the C-terminus.  It has been suggested that phosphorylation of 
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Y1065 could inhibit the Vh-Vt interaction without affecting actin-binding[63].  Cells that 
contain a vinculin mutant with both Src phosphorylation sites (Y100F/Y1065F) mutated 
exhibited decreased cell spreading relative to wild-type vinculin, indicating a physiological 
role for Src phosphorylation[63].    
 
6.   Vinculin Tail Self-Association 
 There is some disagreement in the field concerning self-association of vinculin.  Early 
work, using a variety of methods including overlay assays, infrared attenuated total reflection 
spectroscopy, and electron microscopy, suggested vinculin was capable of self-association.  
Electron microscopy  implicated the tail domain as the strongest point of interaction[2, 20, 
64-66].  It should be noted, however, that most of the methods used in these experiments 
involved either 1) vinculin interacting with a surface or 2) conditions where additional 
ligands may be present, which raises the question of whether surface or ligand induced 
conformational changes could have occurred.  The tail domain of vinculin has been shown to 
dimerize in the presence of actin or acidic phospholipids, but was reported to be a monomer 
in solution[41, 43, 67].  The crystal structure of Vt was also solved as a dimer, although this 
dimer structure was distinct from the model of actin induced dimerization[25, 43].  The 
crystallographic dimer involves a hydrophobic surface at the top of helices 4 and 5, a surface 
also involved in the Vh(D1)-Vt interaction.  While the actin induced Vt dimer is thought to 
be important for the F-actin bundling activity of vinculin, it is unknown whether the crystal 
dimer is physiologically relevant.  However, based on the exposed hydrophobic nature of the 
crystallographic dimer interface, which is freed when Vt is separated from Vh, it is not 
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unreasonable to speculate that this site may be involved in some type of interaction, 
following the release of the Vh-Vt interaction. 
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Figure 1.1:  The full length crystal structure of vinculin (PDB ID 1ST6) is comprised of 8 
helical bundles that are organized into tandem pairs.  The first three tandem pairs (D1 colored 
red, D2 colored yellow, and D3 colored magenta) contains two four-helix bundles with one 
long helix connecting them and make up the head domain of vinculin (Vh).  The “neck” 
domain, comprising D4 and a flexible linker, is colored green.  The tail domain (Vt) is 
colored blue, and is held by the clamp-like head domain.   
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Figure 1.2:  The tail domain of vinculin (residues 879-1066) is composed of a bundle of five 
amphipathic helices, with an N-terminal strap and C-terminal extension.  The structures 
represented here are taken from the full length vinculin structure (PDB ID 1ST6).  A)  The 
N-terminal strap and C-terminal extension of Vt are highlighted in green and yellow 
respectively.  The hydrophobic hairpin in the C-terminus is highlighted in red.  Major 
interactions between the termini and the helical bundle are labeled, including L1056 and 
W1058 in the C-terminus, and D882 and F885 in the N-terminal strap.  B)  The basic ladder 
and basic collar are highlighted on the molecular surface, colored by electrostatic potential.  
The first structure in both A) and B) are depicted in roughly the same orientation.  
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Chapter II. 
Backbone 1H, 13C, and 15N NMR Assignments of the Tail Domain of Vinculin 
 
A.  Introduction 
 Vinculin is a 116 kDa highly conserved cytoskeletal protein that localizes to both 
cell-matrix and cell-cell contacts and plays an important role in the linkage between 
transmembrane receptors (integrins or cadherins) and the actin cytoskeleton [1].  Vinculin is 
composed of an N-terminal head domain (Vh), a flexible neck domain, and a C-terminal tail 
domain (Vt).  Each domain contains binding sites for multiple ligands.  In addition to an 
important auto-inhibitory interaction with Vh, Vt binds F-actin, paxillin, and acidic 
phospholipids.  However, these interactions are at least partially occluded in the intact 
protein due to auto-inhibitory interactions with Vh.  The activation of vinculin requires 
release of the head/tail interaction, and is thought to require combinatorial binding of ligands 
to both Vh and Vt [2]. 
Vinculin is essential in development, as vinculin null embryos die early in 
embryogenesis [3].  Cells lacking vinculin are highly metastatic, highly motile, and resistant 
to apoptosis and anoikis, suggesting that vinculin functions as a tumor suppressor protein.  
The C-terminus of vinculin appears to play a critical role here, as a  C-terminal fragment 
containing Vt, was shown to restore both apoptosis and anoikis in vinculin null cells [4].  In 
addition to cancer, deregulation of vinculin contributes to other disease states, as mutations in 
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the vinculin gene have been linked to both hypertrophic and dilated cardiomyopathy, while 
decreased expression of vinculin is correlated with a predisposition to stress-induced 
cardiomyopathy [5, 6].  In order to elucidate the role of vinculin in both physiological and 
pathophysiological states, a detailed understanding of its activation, function, and ligand 
interactions is needed. 
 
B. Methods and Experiments 
1.  Expression and Purification 
 Escherichia coli strain BL21(DE3) was transformed by electroporation with a 
pET15b vector (Novagen) containing the tail domain of vinculin (G. gallus, 879-1066), as 
previously described [7].  Uniformly 15N or 13C/15N isotopically enriched Vt was grown in 
M9 minimal media containing 1 g/L 15NH4Cl, 2 g/L 13C6-glucose (Spectra) in H2O.  
Perdeuterated Vt was grown in M9 minimal media containing 1 g/L 15NH4Cl, 2 g/L 2H7-13C6-
glucose (Spectra) in 99% D2O.  Bacterial cultures were grown at 37°C until reaching an 
optical density of 0.6, at which point Vt expression was induced by the addition of 0.25 mM 
IPTG and grown for 4-5 hours.  The bacteria were harvested by centrifugation and 
resuspended in lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 5 mM Imidizole, 0.1% β-
mercaptoethanol) and lysed by sonication.  Vt was initially purified using by affinity 
separation using Ni-NTA Agarose beads (Qiagen).  Following elution from the Ni-NTA 
beads, Vt was exchanged into thrombin cleavage buffer (20 mM Tris, pH 7.5, 500 mM NaCl, 
2.5 mM CaCl2, 0.1% BME) by dialysis. The 6-His tag was cleaved by thrombin and removed 
by dialysis in the same buffer.  Vt was then further purified by cation-exchange 
chromatography using a HiPrep 16/10 SP XL column (GE Healthcare Life Sciences) with a 
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0.05-1 M NaCl gradient at pH 7.5.  In some cases insoluble Vt was refolded and purified by 
resuspending cell pellets in 6M guanidinium chloride (GdmCl) prior to sonication.  Vt was 
bound to Ni-NTA beads under denaturing conditions and refolded by removal of the GdmCl 
through dialysis.  After refolding, thrombin cleavage and cation-exchange chromatography 
was performed as described above.  Perdeuterated Vt was purified under denaturing 
conditions to ensure the back-exchange of amide protons to 1H. 
 
2.  Nuclear Magnetic Resonance Spectroscopy 
 NMR spectra of Vt were collected at 37°C on Varian Inova 600, 700, and 800 MHz 
spectrometers.  Select spectra were collected on Varian Inova 700 and 800 MHz 
spectrometers equipped with cryogenically cooled probe heads.  The NMR buffer contained 
10 mM K2HPO4, 50 mM NaCl, 0.01% NaN3, 2 mM DTT at pH 5.5, in 90% H2O and 10% 
D2O.  Backbone assignments were determined using 1H-15N HSQC, HNCO, HN(CA)CO, 
HNCA, HNCACB, HN(CA)CB, HN(CO)CA, and HN(COCA)CB experiments.  
Assignments were also verified where possible by HN-HN NOESY cross peaks obtained 
from 3D 15N-edited NOESY data.  NMR data was processed using NMRPipe/NMRDraw [8] 
and analyzed using NMRView [9]. 
 
C.  Assignments and Deposition 
 
 The Vt domain employed for this study, comprises residues 879-1066 of full length 
vinculin, and was crystallized as a dimer with the two monomer units packed in an 
‘orthogonal’ arrangement, each containing an anti-parallel five helix bundle fold [7].  
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Consistent with previous observations of Vt dimerization, our NMR, analytical 
ultracentrifugation, isothermal titration calorimetry, and fluorescence anisotropy studies all 
indicated that Vt is significantly dimeric at the concentrations used for NMR (0.3 mM).  
Standard 3D triple resonance NMR data on Vt showed poor magnetization transfer 
efficiency, consistent with a 43 kDa dimer at these concentrations.  Perdeuteration of Vt 
improved efficiency of magnetization transfer in triple resonance NMR experiments, making 
sequential assignment possible.  However, concentrations were limited to 0.3 mM.  At higher 
Vt concentrations, magnetization transfer decreased significantly suggesting further 
oligomerization likely occurs.  We were able to determine sequence specific assignments for 
84.24% of the non-proline 15N and amide proton resonances.  We were also able to obtain 
86.7%, 88.83%, and 82.98% of the 13CO, 13Cα, and 13Cβ resonances assignments, 
respectively.  The majority of the unassigned residues fall in one region of the protein 
between residues 897 and 919.  This region appears to be in intermediate exchange on the 
NMR time scale with backbone resonances not detectable.   In the crystal structure of Vt [7], 
this region packs against the N-terminus which is seen in multiple conformations, possibly 
explaining the observed exchange broadening.  Despite deuteration, complete side chain 
assignments could not be obtained due to poor magnetization transfer efficiency.  Vt NMR 
assignments have been deposited in the BMRB with accession number 15653. 
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Figure 2.1:  2D 1H-15N HSQC spectrum of uniformly [2H,15N,13C]-labeled Vt collected on a 
Varian Inova 700 MHz spectrometer at 37 ºC.  The sample contained 0.3 mM Vt, 10 mM 
K2HPO4, 50 mM NaCl, 0.01% NaN3, and 2 mM DTT at pH 5.5 in 90% H2O and 10% D2O.  
NMR resonance assignments are numbered according to the full length G. gallus vinculin 
protein sequence.  To improve clarity, some side chain resonances are labeled with “sc”.  For 
resonances which appear in multiple conformations, peaks associated with the minor 
conformation are labeled with “mc”.   
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Chapter III. 
The Role of pH and Histidine 906 
 
A.  Introduction 
Contacts between cells (cell-cell) and with the extracellular matrix (cell-matrix) 
regulate a wide variety of critical cellular processes including cell growth, migration, 
differentiation, and cell death[1-3].  Aberrant regulation of these processes contributes to a 
number of human diseases, including cancer[4].  The highly conserved cytoskeletal protein, 
vinculin,  is found in both cell-cell and cell-matrix contacts [5], is essential for 
embryogenesis[6], and plays an important role in regulating cell morphology and 
migration[7].  Vinculin is a large,  approximately 116 kDa protein consisting of an amino-
terminal "head" domain (~ 90 kDa) and a carboxy-terminal "tail" domain (~ 21 kDa) 
connected by a flexible hinge region.  The vinculin tail (Vt)  domain forms auto-inhibitory 
contacts with the vinculin head (Vh) domain and binds several ligands including F-actin, 
paxillin, PKCα and acidic phospholipids [8-15].  Auto-inhibitory contacts between the head 
and tail domain are believed to downregulate vinculin function by preventing the interaction 
of multiple ligands [11-13, 16, 17].  On the flip side, vinculin activation requires release of 
auto-inhibitory contacts.  Current models of vinculin activation have proposed that a 
combinatorial input of multiple ligands is necessary to release interactions between the head 
and tail domain.  For example, acidic phospholipid or F-actin binding to the tail domain, 
when coupled with talin association with the head domain are believed to modulate vinculin 
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activity [18-21].  The binding of these ligands is believed to induce conformational changes 
in both the head and tail domains causing disruption of auto-inhibitory contacts [18, 19, 22, 
23].  One study suggested that a single histidine residue (H906) in the vinculin tail domain 
(Vt) is critical for  both  a pH- and lipid-dependent conformational change in Vt, which in 
turn, can modulate vinculin head/tail interactions [24]. 
Several crystal structures of vinculin are now available [18, 19, 22, 25].  The Vt 
domain was solved at pH 5.0, and found to possess an anti-parallel, five helix bundle fold.  
The tail domain adopts a similar structure in the context of the full length protein, despite 
differences in the pH at which the structures were solved.   In addition to the helix bundle 
fold, Vt contains an N-terminal “strap” (residues 879 to 893) that exists in an extended 
conformation and forms interactions with residues along the helix 1-2 face and the C-
terminus.   In particular, F885 in the strap packs against the H906 side chain in helix 1, and 
D882 of the strap forms electrostratic interactions with S914, K924, K1061, and Y1065 
(located in the loop between helices 1 and 2, helix 2, and the C-terminus respectively).   In 
the isolated Vt domain solved at pH 5.0, the strap is observed in multiple conformations, 
suggesting conformational mobility.   
Histidine 906 has been implicated in both pH and lipid-induced Vt conformational 
changes, which in turn affect  auto-inhibitory contacts between the head and tail domain[24].  
To better characterize the role of H906 in pH dependent Vt conformational changes, we 
investigated whether the protonation state of H906 influences Vt structure using NMR and 
CD spectroscopy.  Although a previous CD study indicated that protonation/deprotonation of 
H906 promotes a change in Vt conformation[24], results obtained from our NMR and CD 
studies do not support a large scale conformational change in Vt over a pH range from 5.5 to 
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7. 5.  Mutation of H906 to alanine cause localized chemical shift perturbations in helices 1 
and 2 and the N-terminal strap, consistent with perturbation of the F885/H906 interaction 
resulting in release of the strap from the helix 1-2 interface.  However, loss of this contact 
does not appear to cause a large scale conformational change in the Vt five helix bundle fold.  
As H906 has also been implicated in pH-dependent Vt self-association[24], we employed 
NMR and analytical ultracentrifugation (AUC) approaches to investigate whether Vt 
undergoes pH-dependent self-association.   The isolated Vt domain was crystallized as a 
dimer at pH 5.0 with the site of dimerization located in the upper portions of helices 4 and 
5[19].  Our NMR data support Vt self-association in the solution state, with the dimerization 
interface consistent with that observed by crystallography.  However, in contrast to a 
previous report[24], our AUC and NMR results indicate that Vt does not undergo a monomer 
to dimer transition between pH 5.5 and pH 7.5. Thus, our overall results indicate that Vt does 
not undergo a pH-dependent change in structure, and retains the ability to self-associate 
between pH 5.5 and pH 7.5. 
 
B.  Materials and Methods 
1.  Protein expression and purification 
The tail domain of vinculin (Vt) comprising residues 879-1066 of chicken vinculin 
(98.9% identity with human vinculin) was expressed with a N-terminal His-tag[19].  The Vt 
construct was transformed into E. coli strain BL21(DE3), and expression of Vt induced upon 
addition of 0.25 mM IPTG at 37°C.  Cells were grown for 5 hrs and lysed by sonication in a 
buffer containing 20 mM Tris, pH 7.5, 150 mM NaCl, 5 mM Imidizole, 0.1% β-
mercaptoethanol (BME).  Soluble protein was separated by centrifugation for 1 hour at 
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25,000g.  Vt was initially purified by affinity separation using Ni-NTA Agarose beads 
(Qiagen).  The bound protein was washed and eluted with lysis buffers containing 60 mM 
and 500 mM Imidizole, respectively.  The eluted protein was dialyzed into Thrombin 
cleavage buffer (20 mM Tris, pH 7.5, 500 mM NaCl, 2.5 mM CaCl2, 0.1% BME) and the 
His-tag was cleaved by incubation with thrombin (~1 unit per 5 mg protein) overnight at 37° 
C.  Thrombin was then removed by dialysis in the same buffer.  Vt was then further purified 
by cation-exchange chromatography (HiPrep 16/10 SP XL column from GE Healthcare Life 
Sciences) in a buffer containing 20 mM Tris (pH 7.5), 2.5 mM ethylenediaminetetraacetic 
acid (EDTA), and 0.1% BME with a 0.05-1 M NaCl gradient.  In some cases insoluble Vt 
was refolded and purified by resuspending cell pellets in 6M guanidinium chloride (GdmCl) 
prior to sonication.  GdmCl-treated Vt was purified using a similar procedure as for soluble 
Vt, except that purification using Ni-NTA Agarose beads was carried out under denaturing 
conditions.  Vt was subsequently refolded by removal of the GdmCl by dialysis in a buffer 
containing 20 mM Tris, pH 7.5, 500 mM NaCl, 0.1% BME.  The His-tag was removed and 
Vt further purified by cation-exchange chromatography, using the procedures described 
above for the natively folded protein.  1H-15N HSQC spectra were acquired on 15N-enriched 
refolded Vt and natively folded Vt, to verify similar spectral features and proper refolding.  
The Vt mutant, Vt H906A, was expressed and purified using procedures described above for 
wild-type Vt. 
 
2.  Nuclear Magnetic Resonance Assignments 
The nuclear magnetic resonance (NMR) assignments for the majority of the backbone 
1HN, 15N, 13Cα, 13CO, and side chain 13Cβ resonances were determined for wild-type Vt.  The 
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assignments and experimental details have been deposited in the Biological Magnetic 
Resonance Data Bank (http://www.bmrb.wisc.edu/), accession number 15653.  In brief, 
NMR assignments were determined using a standard series of triple resonance experiments 
(1H-15N HSQC, HNCO, HN(CA)CO, HNCA, HNCACB, HN(CA)CB, HN(CO)CA, and 
HN(COCA)CB)[26] on  (2H, 13C, 15N)-enriched Vt in a buffer containing 10 mM K2HPO4, 
50 mM NaCl, 0.01% NaN3, 2 mM dithiothreitol (DTT) at pH 5.5, in 90% H2O and 10% D2O.  
NMR resonance assignments for Vt H906A were determined using the wild-type 
assignments as a starting point, and were confirmed from HNCO, HNCA, and HN(CA)CB 
spectra on (13C, 15N)-enriched labeled Vt H906A.    
 
3.  NMR Samples 
Bacteria containing the Vt construct[19] were grown in minimal media containing 
1g/L 15N-NH4Cl (Spectra Stable Isotopes).  Vt protein was expressed and purified as 
described above and exchanged into NMR buffer (10 mM Potassium Phosphate, 50 mM 
NaCl, 2mM DTT, 0.1% NaN3 and 10% D2O) using an Amicon Ultra centrifugal filter device 
(10000-dalton molecular weight cutoff, Millipore).  Protein concentration was determined by 
UV absorbance (280 nm, ε = 17990 M-1 cm-1).   
 
4.  NMR Spectroscopy  
NMR experiments were conducted on a Varian INOVA 700 MHz spectrometer at 37° 
C.  1H-15N HSQC spectra were collected on uniformly 15N-enriched wild-type and Vt H906A 
in NMR buffer (10 mM Potassium Phosphate, 50 mM NaCl, 2 mM DTT, 0.1% NaN3 and 
10% D2O).   The data was processed with NMRPipe[27] and analyzed with NMRView[28].  
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1H-15N HSQC spectra were collected over a pH range from 5.5 to 7.5 on 150 µM wild-type 
Vt and Vt H906A protein samples.  Weighted chemical shifts were calculated using the 
following equation: 
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5.  Circular Dichroism 
All circular dichroism (CD) data were collected using an Applied Photophysics 
Pistar-180 spectrometer.  The CD buffer contained 10 mM Potassium Phosphate, 50 mM 
Na2SO4, 1 mM DTT, at either pH 5.5 or 7.5 and 25° C.  Near UV (ultraviolet) CD spectra 
(350-250 nm) were collected using 450 µM protein samples.  Far UV CD spectra (260-190 
nm) were collected using 5 µM protein samples.  In both cases, spectra were recorded in 0.5 
nm steps, averaging over 100,000 samplings per step.  A smoothing function using a three 
point window was applied to all spectra.      
 
6.  Analytical Ultracentrifugation 
 Sedimentation equilibrium experiments were performed using a Beckman Optima 
XL-I analytical ultracentrifuge equipped with absorbance optics. A Ti50 8-hole rotor was 
used with six-sectored centerpieces. Wild-type Vt and Vt H906A, each at three different 
concentrations (150 µM, 300 µM, and 450 µM), were analyzed at both pH 5.5 and pH 7.5 in 
a buffer containing 10 mM Potassium Phosphate, 50 mM NaCl, and 2 mM DTT.  Samples 
were spun at 20° C, at 19,000 rpm for 18 hours, and absorbance scans were recorded every 2 
 36 
hours.  Due to high absorbance at 280 nm, data were collected at 305 nm (absorbance of all 
samples was between 0.2 and 0.95). Equilibrium was assumed to have been reached when 
the difference between two consecutive absorbance profiles was zero. The meniscus-
depletion method was used to determine absorbance offsets after centrifugation of the 
samples at 40,000 rpm for 6 h[29]. Data were analyzed with Beckman XL-A/XL-I Analysis 
Software Version 4.0, and fit to a monomer/dimer model using a partial specific volume of 
0.736.   
 
C.  Results 
The tail domain of vinculin (Vt) has been reported to undergo an H906-dependent 
conformational change as a function of pH and acidic phospholipid binding[24].  
Intriguingly, H906 has also been linked to pH dependent Vt self-association[24].  Based on 
these findings, it was speculated that H906 plays a key role in the conformational dynamic 
properties of Vt and thus in the regulation of vinculin function.  To this end, we have 
employed NMR, CD, and AUC approaches to better characterize the role of H906 in pH- and 
lipid-dependent Vt conformational changes. 
 
1.  Mutation of Histidine 906 to Alanine does not significantly alter Vt structure 
As mutations have the potential to alter protein structure and therefore significantly 
change the interpretation of experimental results, we employed CD and NMR spectroscopy 
to determine whether mutation of histidine 906 to alanine alters the conformation of Vt.  
Circular dichroism (CD) spectroscopy can be used to probe both secondary and tertiary 
structural alterations in proteins[30].  Far-UV (190-250 nm) CD is sensitive to the 
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conformation of the peptide bond and therefore secondary structure of proteins and is often 
used to estimate the percent of secondary structure (i.e., α-helix or β-sheet) present.  Near-
UV (250-350 nm) CD can be used to detect aromatic side chain packing interactions in 
proteins, and is thus a useful probe of tertiary structure[30].  We obtained virtually identical  
near and far-UV CD spectra for both wild-type Vt and the Vt H906A variant at pH 7.5 
(Figure 3.1), indicating that both the overall helical content and the tertiary packing of 
aromatic residues in Vt are not significantly altered by mutation of histidine 906 to alanine. 
However, as near and far-UV CD provide information on the average of all 
chromophores that absorb at the wavelength of interest in the molecular population,  it is not 
possible to obtain residue specific information.  To more specifically characterize site 
specific spectral perturbations in Vt resulting from mutation of H906, we employed 
multidimensional heteronuclear Nuclear Magnetic Resonance (NMR) spectroscopy.  
Uniformly 15N-enriched wild-type Vt and the H906A Vt proteins were expressed and 
purified as described in Methods, and 2D NMR heteronuclear correlation spectra collected.   
1H-15N Heteronuclear Single Quantum Coherence (HSQC) spectra detect signals for protons 
attached to 15N nuclei, and can provide a residue specific probe for each NH pair in wild-type 
and H906A Vt.  The NH resonance is sensitive to changes in its electrochemical 
environment. By analyzing the chemical shift and/or intensity change in NH resonances 
corresponding to each residue, perturbations resulting from the mutation (Vt H906A) can be 
assessed.  As is shown in Figure 3.2, the majority of residues in Vt are unaffected by the 
mutation.  A small subset of NH resonances exhibit chemical shift changes greater than 0.1 
ppm (13), and four additional NH resonances exhibit significant loss of intensity.  The 
residues associated with these NH resonances are proximal to the site of mutation (H906) in 
 38 
the three dimensional structure, and are displayed in Figure 3.3.  NH resonances associated 
with residues that exhibit changes in either chemical shift or intensity almost all localize to 
the N-terminal strap of Vt and the surface of helices 1 and 2 that contact the strap.  In crystal 
structures of Vt and full length vinculin, H906 packs against the side chain of the N-terminal 
strap residue, F885.  It is likely that this interaction is disrupted by mutation of the histidine 
aromatic side chain, resulting in loss of contacts between the strap and helix 1, consistent 
with the chemical perturbations observed at these sites.    
 
2.  The conformation of Vt is largely unaltered between pH 5.5 and 7.5 
 It was previously reported that Vt undergoes a pH dependent conformational change.  
However, this study employed far-UV CD, which is sensitive only to secondary 
structure[24].  To assess the effects of pH changes on the secondary and tertiary structure of 
Vt, both near and far-UV CD spectra were acquired on wild type Vt and Vt H906A at pH 5.5 
and 7.5.   Inspection of Figure 3.4, shows virtually identical near and far-UV CD spectra at 
pH 5.5 and 7.5 for both Vt and Vt H906A, suggesting that neither the secondary or tertiary 
structure of Vt or Vt H906A differs between pH 5.5 and pH 7.5.  As noted previously, CD 
does not provide residue specific information.  To complement CD analyses, NMR studies 
were conducted. 
 
1H-15N HSQC spectra were collected at pH values ranging from 5.5 to 7.5 for both Vt 
and Vt H906A.  The chemical shift perturbations for all detectable resonances were analyzed 
with the results are shown in Figure 3.5.  For both wild-type and H906A Vt, the largest 
chemical shift change was observed for the H1025 NH resonance.  Almost all other 
significant perturbations (> 0.15 ppm) were from residues close to H1025, while the vast 
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majority of resonances showed no significant perturbation (< 0.1 ppm).   Thus, our NMR and 
CD data indicate that the neither the conformation of wild-type Vt or Vt H906A is 
significantly altered between pH 5.5 and 7.5.  Based on the small and localized nature of the 
chemical shifts around H1025, it is likely that these chemical shift perturbations simply 
represent the protonation/deprotonation of the histidine side chain rather than a localized 
conformational change.  We could not detect and therefore assign NH resonances near to and 
including H906 (904-914), presumably due to broadening of these resonances by 
conformational exchange on the intermediate NMR time scale.  However, our findings that 
the NH resonances corresponding to E884, K924, A927, L928, which are proximal to this 
site, do not significantly change as a function of pH, indicates that either H906 does not 
titrate over this pH range due to interactions with the strap or that deprotonation of this side 
chain does not cause a large scale conformational change in the helix bundle. 
 
3.  Vinculin Tail Self-Association 
 Evidence for vinculin tail domain dimerization and oligomerization has been 
observed in both the presence and absence of F-actin and acidic phospholipids[19, 24, 31, 
32].  As noted earlier, the vinculin tail domain was crystallized at pH 5.0 as a dimer[19].  
Moreover, studies by Miller et al (2001) indicate that Vt undergoes pH-dependent self-
association with H906 playing a critical role.  To better characterize Vt self-association and 
the role of H906 in the pH dependence, we have conducted analytical ultracentrifugation 
(AUC) studies. 
 The self-association of wild-type Vt and Vt H906A was analyzed by AUC at pH 5.5 
and pH 7.5.  All data was fit to a monomer/dimer model of self-association.  Apparent Kd 
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values and a representative monomer/dimer fit are reported in Figure 3.6.  Interestingly, 
Miller et al (2001) reported that Vt was monomeric at pH 7.0, but self-associated at pH 5.5 as 
determined by gel filtration chromatography[24].  However, our AUC data indicates that Vt 
is capable of self-association at both pH 5.5 and 7.5, with a Kd of 243 and 134 µM, 
respectively.  Moreover, we observed a decrease in the dissociation constant at pH 7.5 
relative to pH 5.5,  which is reverse of the trend reported by Miller et al[24].  A decrease in 
self-association was observed with Vt H906A at both pH 5.5 and pH 7.5 relative to wild-type 
Vt, however all apparent Kd values were >100 µM, suggesting this self-association may not 
be biologically relevant.     
 
D.  Discussion 
Ligand binding to both the vinculin head and tail domain has been reported to induce 
conformational changes in vinculin that modulate its function[19, 22, 32, 33].  In particular, 
binding of F-actin and acidic phospholipids to the tail domain has been reported to cause 
both a change in conformation and oligomerization state[19, 32].  Studies reported by Miller 
and Ball (2001) supported a H906-dependent conformational change in Vt in response to pH 
changes and acidic phospholipid binding [24].  In addition, the protonation state of H906 was 
reported to modulate Vt self-association.  To better understand the molecular basis for the 
role of H906 in pH–dependent Vt conformation and dimerization, we conducted a series of 
biophysical studies on Vt and a Vt H906A variant. 
 H906 was previously proposed as a critical residue in lipid and pH-dependent Vt 
conformational changes[24], based on far-UV CD studies of wild-type Vt and Vt H906A.   
As far UV CD (190-250 nm) is sensitive only to secondary structure, we were interested in 
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further characterizing whether mutation of H906 to alanine affects the tertiary structure of Vt.  
We conducted near-UV CD (250-350 nm) on wild-type Vt and the H906A variant, as near-
UV CD spectra are sensitive to differences in packing interactions associated with aromatic 
amino acids and therefore tertiary structure.  Interestingly, we found both the near and far 
UV CD spectra of Vt and Vt H906A were similar at pH 7.5 (Figure 3.1).  These results 
indicate that, within the resolution of CD, that mutation of histidine 906 to alanine does not 
alter the secondary or tertiary fold of Vt at pH 7.5.  We also conducted Nuclear Magnetic 
Resonance (NMR) studies, as NMR spectroscopy can report on site specific differences in 
the chemical environment of residues within wild-type and Vt H906A.  For these studies, 1H-
15N HSQC spectra were collected on 15N-enriched wild-type Vt and Vt H906A to analyze 
chemical shift differences in the amide 15N and proton resonances for Vt and Vt H906A.  We 
found that the majority of the amide proton resonances in Vt H906A are not significantly 
changed from wild-type Vt, indicating that the overall conformation is not altered by the 
mutation (Figure 3.2), consistent with CD data.  Of the resonances that do exhibit chemical 
shift changes, the changes are small and localized to the site of mutation.  In addition, as 
NMR chemical shifts are very sensitive to surrounding chemical environment, changes in 
chemical shifts do not necessarily represent conformational changes.  For residues in the 
immediate vicinity of H906, the removal of the histidine side chain is likely to alter the 
chemical shift associated with neighboring residues even in the absence of a conformational 
change.  The additional chemical shift changes seen are tenably explained upon inspection of 
the known crystal structure.  In the crystal structures of both Vt and full length vinculin, 
histidine 906 is located in helix 1 and the histidine side chain extends away from the helical 
bundle and interacts with the side chain of phenylalanine 885 in the N-terminal strap of 
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Vt[18, 19].  The N-terminal strap is held in an extended conformation along the interface of 
helices 1 and 2, mainly via interactions involving F885 and D882.  Interactions between the 
side chains of F885 and H906 are likely to stabilize contacts with the helix 1-2 interface and 
the extended conformation of the strap.  Intriguingly, in the crystal structure of Vt, the strap 
is observed in two distinct conformations, suggesting conformational flexibility[19].  
Disruption of the interaction between H906 and F885 is likely to promote increased 
conformational flexibility in the strap, though additional interactions between residues in the 
strap and the helical bundle should still restrain the conformation of the strap to some degree.  
Mutation of histidine 906 to alanine should increase the conformational flexibility of the N-
terminal strap, allowing increased sampling of alternate strap conformations, due to 
disruption of contacts between the N-terminal strap and the helical bundle.  These 
conformations are likely also sampled in the wild-type structure although at lower frequency.  
The chemical shift changes observed for NH resonances associated with the strap and the 
surface of helices 1 and 2 between wild-type Vt and Vt H906A, are consistent with increased 
conformational flexibility of the strap.  The lack of chemical shift changes in the remaining 
helices of the bundle suggest that there are not significant changes in helices 1 and 2, as 
structural alterations in these helices are likely to perturb the chemical environment of the 
other helices within the helical bundle. 
  CD studies by Miller and Ball (2001) concluded that although the conformation of Vt 
and Vt H906A are similar at pH 7.0, differences were observed at pH 5.5.  A change in the 
far UV CD spectrum of wild-type Vt between pH 5.5 and 7.0 was interpreted as a pH-
dependent conformational change.  In this previous study,  far UV CD spectra of Vt H906A, 
but not wild-type Vt, was reported to be similar at both pH 7.0 and pH 5.5, suggesting that 
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H906 was critical for a pH dependent conformational change in Vt[24].  To further 
characterize this reported conformational change, we conducted both near and far UV CD of 
both wild-type Vt and Vt H906A at pH 7.5 and pH 5.5.  However, comparison of CD spectra 
for both Vt and Vt H906A, showed no significant spectral differences at either pH 7.5 or pH 
5.5 (Figure 3.4).  Thus, our CD results do not support a pH dependent conformational change 
for either wild-type Vt or Vt H906A.  As these results differed from findings of Miller and 
Ball, we sought to corroborate these data with additional NMR studies. For these studies, 1H-
15N HSQC NMR spectra were collected at pH values between 5.5 and 7.5 for both 15N-
enriched wild-type Vt and Vt H906A.  Heteronuclear 2D spectra as a function of pH provide 
residue specific probes of pH dependent changes.  The only amino acid side chain that 
normally undergoes protonation/deprotonation over this pH range is that of histidine (δ1 
proton), consistent with our observation that the histidine NH resonances show the largest 
changes in chemical shift.   Vt has two native histidine residues, H906 and H1025.  Histidine 
1025 exhibits large chemical shift changes over the pH range studied, consistent with the 
titration of its side chain.  Unfortunately, the NH resonance associated with H906 is not 
detected in our spectra, presumably due to chemical exchange on an intermediate time scale 
resulting in broadening.  However, of all detectable residues, the only significant chemical 
shift changes are localized to H1025, consistent with the protonation/deprotonation of its side 
chain between pH 5.5 and 7.5.  Although H906 could not be measured, residues within 3-4 
amino acids from H906 and those closest in the three dimensional structure were detectable 
and showed small/insignificant chemical shift changes.  The majority of NH resonances in Vt 
exhibit insignificant chemical shift changes between pH 5.5 and 7.5 (Figure 3.5).  This is 
strong evidence that the conformation of Vt is not significantly altered by pH, consistent with 
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CD data.  Additionally, the pH dependent chemical shift changes observed in HSQC spectra 
of both Vt and Vt H906A are virtually identical, indicating that mutation of H906 does not 
alter pH-dependent spectral changes observed for Vt. 
 Vinculin tail self-association  has been reported under a variety of different 
conditions, by a number of groups[8, 19, 24, 31, 32].  In one report[24], Vt was reported to 
exist in its monomeric state at pH 7.0, but self-associate at pH 5.5.  In contrast, the Vt H906A 
variant was reported be insensitive to pH-dependent self-association.  Based, on these 
findings, H906 was proposed to play an important role in Vt self-association.  Interestingly, 
the crystal structure of Vt was solved as a dimer showing H906 to be distant from the site of 
dimerization, raising the question of how H906 could regulate this self-association.  As self-
association is likely critical for the F- actin bundling function of Vt[8, 31, 32], we were 
interested in further characterizing Vt self-association in solution.  AUC and NMR studies 
were conducted to measure Vt self-association.  Concentration dependent NMR spectral 
changes support the existence of the Vt dimer observed by crystallography, at both pH 7.5 
and pH 5.5.   The concentration dependence of the amide resonances in HSQC spectra were 
fit to a monomer dimer model and provided an approximate Kd between 200 and 300 µM at 
pH 5.5 (data not shown).  As the high protein concentrations required by NMR and 
complications associated with interpretation of chemical shifts can lead to significant 
uncertainty in the determination of a Kd by NMR, we conducted AUC to better characterize 
Vt self-association.  Initial AUC studies, monitored at 280 nm, with Vt samples between 10 
and 40 µM did not exhibit evidence of self-association (data not shown), consistent with the 
approximate Kd obtained by NMR.  AUC experiments at higher protein concentrations do 
show evidence of self-association for both wild-type Vt and Vt H906A (Figure 3.6).  For 
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both wild-type Vt and Vt H906A, however, the apparent Kd determined by fitting to a 
monomer/dimer model was greater than is commonly observed for physiological 
interactions, suggesting the self-association in the absence of F-actin or acidic phospholipids 
may not be biologically relevant.  It remains unclear if the weak self-association observed in 
solution is relevant to the self-association in the presence of F-actin.  Although all apparent 
Kd measurements determined were >100 µM, the Vt H906A increase in the Kd for self-
association.  For both wild-type Vt and Vt H906A, there is also an increase in self-
association at pH 7.5 relative to pH 5.5.  In all cases, it should be noted that the apparent Kd 
determined by AUC may be complicated higher order oligomerization.  While the AUC data 
was fit to a monomer/dimer model, it is possible that Vt self-association may involve higher 
order oligomerization, in which case the Kd’s determined by a monomer/dimer fit may be 
inaccurate.  Poor magnetization transfer efficiency in heteronuclear NMR experiments and 
some non-random residuals in monomer/dimer fits of AUC data both suggest some higher 
order oligomerization may occur, however the nature and extent of this oligomerization is 
unclear. 
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Figure 3.1:  The circular dichroism (CD) spectra of wild-type Vt and Vt H906A were 
compared to assess potential changes in secondary and tertiary structure.  Far ultraviolet 
(UV) CD, 190-260 nm, is sensitive to changes in the conformation of the peptide backbone 
and therefore secondary structure of proteins.  Near UV CD, 250-350 nm, can detect 
aromatic side chain packing interactions in proteins, and is thus a useful probe of tertiary 
structure.  The far and near UV spectra of Vt and Vt H906A are virtually identical at pH 7.5, 
suggesting that the mutation of histidine 906 to alanine in Vt does not alter either the 
secondary or tertiary structure over this pH range.         
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Figure 3.2:  To specifically characterize site specific spectral perturbations in Vt resulting 
from mutation of H906, 1H-15N Heteronuclear Single Quantum Coherence (HSQC) spectra 
were collected on 15N-enriched Vt and Vt H906A (0.15 mM protein, pH 5.5).  As shown in 
A, minor chemical shift perturbations are observed primarily for backbone HN resonances 
associated with residues in the N-terminal strap and helix 1-2 interface, consistent with 
minimal changes in the overall fold of Vt.  The weighted chemical shift changes for each 
residue are displayed in B.  The majority of residues exhibit perturbations of < 0.05 ppm, 
with perturbations > 0.1 ppm localized to the N-terminal strap and the helix 1-2 interface (see 
Figure 3.3). 
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Figure 3.3:  Residues exhibiting either chemical shift perturbations or significant changes in 
intensity due to mutation of H906 to alanine are highlighted on the structure of Vt (1ST6).  
The site of mutation (H906) is highlighted in magenta.  Residues showing chemical shift 
changes > 0.2 ppm, between 0.15 and 0.2 ppm, and between 0.1 and 0.15 ppm are shown in 
red, orange, and yellow, respectively.  Residues displayed in green exhibit significant 
changes in intensity or broadening of the associated NH resonances.  The residues colored 
grey could not be measured in either wild-type Vt or Vt H906A, presumably due to 
broadening of the NH resonance due to chemical exchange between two or more conformers.  
Almost all residues whose NH resonances chemical shift or intensity perturbations relative to 
wild-type Vt, are localized to the N-terminal strap and the surface of helices 1 and 2 that are 
contacted by the strap.  This is consistent with a localize change in the N-terminal strap of 
Vt, with the overall conformation of the helical bundle largely unaltered. 
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Figure 3.4:  The far and near UV spectra of wild-type Vt and Vt H906A were compared at 
pH 5.5 and 7.5 to assess pH dependent conformational changes.  Both wild-type Vt (A) and 
Vt H906A (B) exhibited no significant differences in either far or near UV CD spectra 
between pH 5.5 and 7.5, suggesting that there is no significant pH dependent conformational 
change for either wild-type Vt or Vt H906A across this pH range.  
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Figure 3.5:  The weighted chemical shift changes in 1H-15N HSQC spectra of wild-type Vt 
(A) and Vt H906A (B) collected between pH 5.5 and 7.5.  For both Vt and Vt H906A, the 
largest chemical shift changes measured correspond to H1025.  The backbone HN resonance 
of H906 is not detectable, presumably due to chemical exchange on an intermediate time 
scale resulting in broadening.  The majority of chemical shift changes are small (< 0.05 
ppm), suggesting there is no overall conformational change in Vt between pH 5.5 and 7.5.  
The largest chemical shift changes are localized to H1025, consistent with titration of the 
histidine side chain over this pH range.  Furthermore, the chemical shift changes observed for 
Vt H906A are nearly identical to wild-type Vt, suggesting that the protonation state of H906 
does not play a role in pH dependent spectra changes observed between pH 5.5 and 7.5. 
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Figure 3.6:  Analytical ultracentrifugation (AUC) studies were conducted on both wild-type 
Vt and Vt H906A to quantify Vt self-association.  Experiments were conducted at 150, 300, 
and 450 µM protein concentrations.  Sedimentation equilibrium curves were fit to a 
monomer/dimer model, and a representative fit is shown in A.  The Kd for self-association 
was observed to be lower at pH 7.5 relative to pH 5.5 for both Vt and Vt H906A, however in 
both cases the association was relatively weak, with Kd values > 100 µM.  Dissociation 
constants determined for monomer/dimer fits are shown in B.  
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Chapter IV. 
Vinculin Tail and Lipid Binding 
 
A.  Introduction 
 Vinculin is a highly conserved cytoskeletal protein which localizes to points of cell 
adhesion and is involved in linking the actin cytoskeleton to the cell membrane[1].   Sites of 
adhesion in which vinculin is enriched include focal adhesions (cell-extracellular matrix), 
adherence junctions (cell-cell), costameres in muscle cells, and intercalated discs in cardiac 
cells[1-3].   At these sites, vinculin is believed to play an important role in cell adhesion 
processes involving regulation of the actin cytoskeleton.  Moreover, vinculin has been linked 
to pathways that control cell growth, differentiation, motility, and survival[4-7].  Vinculin is 
also critical for proper development in model organisms[6, 8] and its loss in cells leads to 
increased motility, invasiveness, and resistance to apoptosis[5, 9, 10].  Decreased vinculin 
expression and mutations have also been associated with human cardiomyopathies[11-14]. 
 Vinculin is a 116 kDa cytoskeletal protein, and early studies by electron microscopy 
and proteolytic cleavage determined it to be made up of a globular head domain (Vh), a 
flexible neck,  and a tail domain (Vt)[15, 16].  The full length structure of vinculin has been 
solved by X-ray crystallography, and has been described as a “bundle of bundles”[17].   Vh 
is composed of 6 helical bundles organized into 3 tandem pairs of bundles while Vt is 
composed of a single helical bundle.  The head and tail domain interact to form a closed, 
auto-inhibited conformation with Vt held “pincer-like” by Vh[17].  Vinculin binds a number 
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cytoskeletal and adhesion proteins including actin, talin, α-actinin, α-catenin, β-catenin, 
vinexin, ponsin, actin-related protein complex (Arp 2/3), vasodilator-stimulated 
phosphoprotein (VASP), and paxillin.  However, many of these interactions are at least 
partially masked in the intact, unstimulated protein due to the auto-inhibitory interactions 
between the head and tail domains[18].  Vinculin has also shown to bind acidic 
phospholipids through its tail domain, and this interaction also appears to be regulated by 
head/tail interactions[19-21], with lipid binding proposed to play a role in vinculin activation 
and focal adhesion turnover[17, 19, 22, 23].  Although vinculin has been shown to bind 
acidic phospholipids, including phosphatidylserine (PS), phosphatidylinositol (PI), and 
phosphatidylinositol 4,5-bisphosphate (PIP2), the relative affinity for various acidic 
phospholipids and phosphoinositides (PPIs) has not been reported.  The inositol ring of PPIs 
can be phosphorylated at three separate positions (not including the phosphodiester linkage at 
position 1), allowing for a number of PPIs with distinct functions.  Three families of 
phosphoinositol phosphate kinases are involved in the production, interconversion, and 
regulation of PPIs[24, 25].  PPIs, including PIP2, have been shown to be regulated both 
spatially and temporally at sites of actin assembly and cytoskeletal remodeling[26-29].  
Although a number of structurally conserved PPI and PIP2 binding motifs have been 
identified[30-32], none have been found within the vinculin tail domain.  Structural studies 
of Vt identified three features proposed to play a role in binding of acidic lipids; a C-terminal 
extension containing a “hydrophobic hairpin”, a “basic collar” of lysine and arginine residues 
surrounding the hydrophobic hairpin, and a “basic ladder” of exposed basic residues along 
the length of helix 3.  A series of vinculin mutagenesis studies have been conducted to 
pinpoint the site of lipid binding to Vt.  However, the data is somewhat difficult to interpret, 
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as the number, location and effectiveness of the mutations vary.  Although some of the 
phospholipid defective variants have been characterized to determine whether the mutation(s) 
effect other ligand binding interactions (i.e., Vh, actin), the structural effects of these 
mutations are largely unknown. Thus, the exact site and mode of phospholipid binding is still 
unclear.  In order to better characterize phospholipid binding interactions with the vinculin 
tail domain (Vt), we have examined the relative ability of various acidic phospholipids to 
associate with the vinculin tail domain using lipid co-sedimentation assays, and performed 
biophysical characterization and lipid binding studies on various Vt mutants. 
     
B.  Materials and Methods 
1.  Protein expression and purification 
Vinculin tail (Vt) constructs containing residues 879-1066 (generously provided by 
Dr. Robert Liddington) and 884-1066 of chicken vinculin in the pET15b vector (Novagen) 
have been described previously[19, 21].  Mutant forms of Vt were produced using the 
QuikChange Site-Directed Mutagenesis Kit (Stratagene) and verified by DNA sequencing.  
Vectors were transformed into E. coli strain BL21(DE3) and cells were grown at 37°C to an 
optical density of 0.6 (600 nm).  Vt expression initiated by addition of 0.25 mM isopropyl β-
D-1-thiogalactopyranoside (IPTG) and cells were grown for a further 5 hrs and harvested by 
centrifugation.  Vinculin was expressed at high level and purified from both the soluble and 
insoluble fraction.  Cell pellets were resuspended in a lysis buffer containing 20 mM Tris, pH 
7.5, 150 mM NaCl, 5 mM Imidizole, 0.1% β-mercaptoethanol (BME) and lysed by 
sonication.  Vinculin, expressed in the soluble fraction was separated from the particulate 
fraction by centrifugation for 1 hour at 25,000 g.  The fraction containing soluble Vt, was 
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purified by affinity separation using Ni-NTA agarose beads (Qiagen).  Vt was washed and 
eluted from the beads using lysis buffer containing 60 mM and 500 mM Imidizole, 
respectively, and then dialyzed into Thrombin cleavage buffer (20 mM Tris, pH 7.5, 500 mM 
NaCl, 2.5 mM CaCl2, 0.1% BME).  The His-tag was cleaved by thrombin (~1 unit per 5 mg 
protein) overnight at 37° C.  Cation-exchange chromatography (HiPrep 16/10 SP XL column 
from GE Healthcare Life Sciences) was used to further purify Vt, using a 0.05-1 M NaCl 
gradient in a buffer containing 20 mM Tris (pH 7.5), 2.5 mM ethylenediaminetetraacetic acid 
(EDTA), and 0.1% BME. 
To purify Vt from the insoluble fraction, cell pellets were resuspended in 6 M 
guanidinium chloride (GdmCl) prior to sonication.  A protocol similar to that used for 
soluble Vt was employed except that purification from Ni-NTA agarose beads was carried 
out under denaturing conditions.  Following elution, GdmCl was removed and Vt refolded by 
dialysis in a buffer containing 20 mM Tris, pH 7.5, 500 mM NaCl, and 0.1% BME.  
Thrombin cleavage to remove the His-tag and further cation-exchange chromatography was 
identical to the procedure for the natively folded protein.  Proper refolding was verified by 
comparison of 1H-15N HSQC spectra acquired on refolded and natively folded Vt (both 15N 
enriched).   
 
2.  Lipid Co-sedimentation 
 Lipid binding to Vt was assessed by co-sedimentation with small, unilamellar vesicles 
(SUV).  The binding of phosphatidylinositol (PI) and phosphatidylserine (PS) were assessed 
in lipid vesicles containing 60% phosphatidylethanolamine (PE), 40% phosphatidylcholine 
(PC) by weight, with either PI or PS replacing PE at the concentration indicated.  The 
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binding of phosphatidylinositol 4,5-bisphosphate (PIP2) was assessed using vesicles 
containing 60% PE, 20% PC, and either 20% PS by weight, with PIP2 replacing PS at the 
concentration indicated.  For example, experiments testing the role of 10% PIP2 employed 
vesicles composed of 60% PC, 20% PE, 10% PS, and 10% PIP2.  Vesicles were produced by 
combining the appropriate lipids suspended in chloroform, to producing a sample containing 
250 µg total lipid.  The mixture was dried using a SpeedVac and then resuspended in 90 µL 
of buffer containing 40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
150 mM NaCl, and 2 mM dithiothreitol (DTT), pH 7.4.  Resuspension and production of the 
SUVs was accomplished by brief sonication with a probe tip sonicator.  10 µL of 100 µM 
protein (in an identical buffer) was added to each vesicle sample, producing a final volume of 
100 µL and a final protein concentration of 10 µM.   Samples were nutated at 4° C for 1 
hour, then centrifuged at 100,000 g for 1 hour.  The supernatant was removed and the pellet 
resuspended in buffer containing 0.1% sodium dodecyl sulfate (SDS), 25 mM glycine, and 
25 mM TRIS, pH 8.3.  Supernatant and pellet samples were analyzed by SDS 
polyacrylamide gel electrophoresis (SDS-PAGE).  Gels were stained with coomassie, 
scanned, and protein levels quantified using ImageJ software[33]. 
 
3.  NMR Samples and Spectroscopy 
Bacterial expressed 15N-labeled Vt protein was produced for nuclear magnetic 
resonance spectroscopy (NMR) studies by growth in M9 minimal media containing 1g/L 
15N-NH4Cl (Spectra Stable Isotopes).  NMR samples were exchanged into NMR buffer (10 
mM Potassium Phosphate, 50 mM NaCl, 2 mM DTT, 0.1% NaN3 and 10% D2O at the 
indicated pH) using an Amicon Ultra centrifugal filter device (10000-dalton molecular 
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weight cutoff, Millipore).   1H-15N Heteronuclear Single Quantum Coherence (HSQC) 
spectra were collected on a Varian INOVA 700 MHz spectrometer at 37° C.  NMR data 
processing and analysis was performed using NMRPipe[34] and NMRView[35]. 
 
4.  Circular Dichroism 
 Circular dichroism (CD) spectra were collected at both near-ultraviolet (350-250 nm) 
and far-ultraviolet (260-190 nm) spectral regions.  All spectra were collected at 25 °C in a 
buffer contained 10 mM Potassium Phosphate, 50 mM Na2SO4, and 1 mM DTT, pH 7.5 
using an Applied Photophysics Pistar-180 spectrometer.  Protein concentrations were 0.45 
mM and 5 µM for near-UV and far-UV respectively.  
 
C.  Results 
1.  The Vinculin Tail Domain Shows Specificity for PIP2 Containing Vesicles Although 
the tail domain of vinculin has been reported to bind acidic phospholipids and 
phosphatidylinositol 4,5-bisphosphate (PIP2), the methods used to assess acidic phospholipid 
binding have varied significantly, making comparison of separate reports on lipid binding 
difficult[17, 19, 21, 22, 36, 37].  To clarify the affinity and specificity of Vt for PIP2, we 
performed co-sedimentation experiments with mixed PE, PC, and PS vesicles, examining the 
effect of increasing PIP2 concentration.  Although Vt has previously been shown to bind to 
pure PS vesicles[21], we found that under physiologically relevant lipid and salt 
concentrations, no significant binding of Vt to PS containing vesicles was observed.  In the 
absence of PIP2, little co-sedimentation of Vt with mixed lipid vesicles containing 60% PC, 
20% PE, and 20% PS vesicles was observed, in 150 mM NaCl (Figure 4.1).  Upon the 
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addition of PIP2 however, a clear concentration dependent co-sedimentation was observed, 
indicating that Vt specifically recognizes PIP2. 
 The vinculin tail domain has also been reported to interact with pure 
phosphatidylinositol (PI) and phosphatidylserine (PS) vesicles.  To ascertain the relative 
affinity of Vt for PI, PS, and PIP2, Vt association was observed in mixed lipid vesicles 
containing each of these lipids.  As shown in figure 4.2, Vt does not bind PI or PS 
significantly in the context of mixed lipid vesicles, and demonstrated a marked preference for 
PIP2 over either PI or PS.  
 
2.  Vt demonstrates loss of tertiary structure in lipid micelles and loses specificity for PIP2 
 As shown in figures 4.1 and 4.2, the vinculin tail domain shows enhanced association 
with PIP2 in lipid co-sedimentation relative to PS and PI.  In an effort to determine the site(s) 
of interaction between Vt with PIP2, we employed circular dichroism (CD) and solution 
nuclear magnetic resonance (NMR) spectroscopy.  In general, information derived from high 
resolution NMR decreases as the molecular size increases.  Hence, we initiated studies of 
phospholipid interactions with Vt using micelles as opposed to larger vesicles.  However, 
introduction of dodecylphosphocholine (DPC), at concentrations that promote micelle 
formation causes a collapse in Vt structure, as determined by both near-UV (ultraviolet) CD 
and  1H-15N heteronuclear 2D NMR. 
Near-UV CD is sensitive to the tertiary packing of aromatic residues and therefore the 
tertiary structure of proteins.  Far-UV CD is sensitive to the conformation of the peptide 
backbone and therefore the secondary structure of proteins.  The far-UV CD of Vt exhibits 
only minor changes in the presence of 100 mM DPC indicating there is no significant change 
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in the secondary structure (Figure 4.3 A).  The near-UV CD spectra, however, exhibits a 
significant los of signal, indicating a loss of tertiary structure (Figure 4.3 A). 
The 1H-15N HSQC NMR spectra detect signals for protons attached to 15N nuclei.  
The backbone NH of each amino acid (with the exception of proline) providing a residue 
specific probe sensitive to changes in its electrochemical environment.  1H-15N HSQC 
spectral dispersion arises from the unique environment of each distinct NH pair.  Loss of a 
distinct, folded structure results in convergence of resonances toward random coil chemical 
shifts (centered at ~8.3 ppm).  The significant loss of spectral dispersion seen in Vt in the 
presence of 100 mM DPC (Figure 4.3 B) is indicative of a significant loss in tertiary 
structure, in agreement with the near-UV CD.  The residual dispersion seen also agrees with 
the persistence of helices suggested by far-UV CD. 
Although Vt has been proposed to undergo a conformational change upon association 
with phospholipids[17], DPC micelles may act as a detergent causing unfolding of Vt.  As Vt 
does not bind to PC containing vesicles, the interaction with DPC micelles may be non-
specific.  Adding to this possibility, a similar collapse in NMR chemical shift dispersion was 
observed in 1H-15N HSQC spectra of Vt in the presence of other micelles tested, including C-
4 PIP2 and 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] (LPPG) (data 
not shown).   
Attempts to map the PIP2 interaction site by NMR using the PIP2 headgroup, D-myo-
Inositol-1,4,5-triphosphate or a short chain (C8) derivative of PIP2 were also unsuccessful 
(data not shown), as a clear, specific binding site was not observed.  These results indicate 
that the head group alone does not have sufficient affinity for Vt to either bind specifically to 
Vt or promote a conformational change necessary for high affinity binding.  
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3.  Vt C-terminal residues stabilize its tertiary fold 
 A C-terminal deletion Vt mutant reported to be deficient in lipid binding has been 
utilized in multiple studies[17, 19, 22, 23].  This mutant, Vt∆C, lacks 15 C-terminal amino 
acids (1052-1066).  The deletion of this fragment has been reported to decrease PIP2 binding 
but does not significantly affect interaction with either actin or the head domain of 
vinculin[19, 23].  However, Vt∆C shows increases susceptibility to protease degradation[19, 
23] and alterations in one dimensional 1H NMR spectra indicating loss of structure [23].  As 
residues in the C-terminus form tertiary interactions with other residues in the tail domain, 
the loss of these residues upon deletion could alter the structure and stability of Vt.  In 
particular, the deletion results in removal of tryptophan 1058 (W1058) which packs against 
tryptophan 912 (W912) that is located at the bottom of helix 1, could alter Vt structure 
resulting in destabilization.  Interestingly, both residues are conserved in all vinculins as well 
as α-catenin, a cell adhesion protein with high homology to vinculin[23, 38].  There is also 
an interaction of the C-terminus and the N-terminal strap of Vt seen in full length 
vinculin[17].  To better understand the role of the Vt C-terminus in lipid binding, we 
conducted NMR and CD analyses of the Vt∆C variant.  As reported previously, we found 
Vt∆C to be significantly more susceptible to protease cleavage than wild-type Vt[19, 23].  
The 2-D 1H-15N (NMR) spectra indicate that the C-terminal deletion results in significant 
loss of tertiary structure.  As shown in Figure 4.4A, the 1H-15N HSQC spectra of wild-type 
Vt displays the spectral dispersion consistent with that of a well folded α-helical protein.  In 
contrast, the 1H-15N spectrum of Vt∆C exhibits increased overlap resulting from a collapse in 
chemical shift dispersion and an increase of resonances with random coil chemical shifts 
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(Figure 4.4 A).  In addition, the majority of resonances exhibit chemical shift changes.  These 
NMR data suggest loss of structural stability upon deletion of the C-terminal residues. 
While the near UV CD (350-250 nm) of Vt∆C could not be directly compared with 
wild-type Vt due to the removal two of the three tryptophan residues in the protein (Trp 
residues represent a majority of the near UV CD in proteins), far UV CD (260-190 nm) 
which is sensitive to the secondary structure of proteins, suggests that the helical content of 
wild-type Vt and Vt∆C are nearly identical (Figure 4.4 B).  Together, this data suggest that 
while the secondary structure of Vt∆C is largely unaltered relative to wild-type Vt, its tertiary 
conformation and stability has been significantly altered. 
 Structural changes in Vt∆C have been attributed at least in part to loss of W1058[23], 
however other residues present in the deleted C-terminal fragment have been suggested to be 
important for lipid binding.  The “hydrophobic hairpin” (TPWYQ at the extreme C-terminus) 
has been postulated to be important for vinculin insertion into the membrane,  and that 
R1057, R1060, and K1061 (part of the “basic collar”) may be involved in binding acidic lipid 
headgroups[19, 22].  To elucidate the role of these residues in Vt structural integrity, we 
generated two new C-terminal deletion mutants, Vt∆C5 and Vt∆C7.  Vt∆C5 is a deletion 
which removes 5 amino acids from Vt that make up the hydrophobic hairpin (TPWYQ), 
whereas in Vt∆C7,  two additional amino acids are deleted, R1060 and K1061, which are 
part of the basic collar.  As shown in Figure 4.5 A, the 1H-15N HSQC spectra of Vt∆C5 is 
nearly identical to that of wild-type Vt, suggesting that the removal of these 5 amino acids 
has a minimal effect on the structure of the protein.  In contrast, the 1H-15N HSQC spectra of 
Vt∆C7 exhibits changes similar to those seen in Vt∆C (chemical shift changes, increase in 
overlap, increase in resonances with random coil chemical shifts), although the comparative 
 65 
spectra changes observed for Vt∆C7  are not as significant as those observed for Vt∆C 
(Figure 4.4 A and Figure 4.5 B).  This NMR data indicates that R1060 and K1061 may play a 
role in maintaining the tertiary fold. 
 
4.  The Role of the N-terminal Strap in PIP2 binding 
 A significant number of mutations have been made in Vt to assess their affect on lipid 
binding.  In addition to the Vt∆C deletion mutant, a variety of basic residues have been 
mutated, targeted predominately to residues in the the “basic collar” and “basic ladder”[17, 
22, 23].  To elucidate lipid binding determinants in Vt, we characterized a series of mutants 
in both Vt (879-1066) as well as a shorter construct of Vt containing residues 884-1066[21].  
For clarity, we will refer to the construct containing residues 884-1066 as Vt∆N and the 
construct containing residues 879-1066 as wild-type Vt or simply Vt. 
The N-terminus of Vt contains a “strap”, which is found in an extended conformation 
along the interface of helices 1 and 2 in the crystal structure of full length vinculin[17].  The 
N-terminal strap is found in multiple conformations in the crystal structure of Vt, suggesting 
conformational flexibility.   In the full length crystal structure, the N-terminal strap forms 
contacts with the main helical bundle through both phenylalanine 885 (F885) and aspartic 
acid 882 (D882).  The side chain of F885 packs against the side chain of histidine 906 
(H906) in helix 1, while D882 makes polar contacts with residues including S914 (helix 1-2 
loop), K924 (helix 2), and K1061 and Y1065 in the C-terminus (Figure 4.6).  Removal of 5 
amino acids from the N-terminal strap of Vt (Vt∆N) results in loss of D882, which makes 
multiple interactions with the helix bundle.and C-terminus 
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Intriguingly, we found the lipid binding capacity of Vt∆N to be significantly different 
from wild-type Vt.  While the lipid binding specificity of Vt∆N was nearly identical to Vt 
(minimal binding to PS and PI, data not shown), the affinity for PIP2 was considerably higher 
(Figure 4.7).  As one of the points of interaction between the N-terminal strap and the helical 
bundle (D882) has been removed in Vt∆N, we hypothesized that the enhancement observed 
in PIP2 binding may be due to release or partial release of the strap.  To test this hypothesis, 
we conducted lipid co-sedimentation assays on two mutants, Vt D882A and Vt H906A.  
Mutation of either of these residues should disrupt interactions with the N-terminal strap.   In 
particular, mutation of H906 to alanine should disrupt packing with F885 while the aspartic 
acid to alanine mutation at 882 should disrupt polar contacts S914, K924, K1061, and 
Y1065.  Results shown in figure 4.7, indicate that both mutants significantly increase the co-
sedimentation of Vt with PIP2 containing lipids, consistent with our hypothesis that release of 
the N-terminal strap increases PIP2 binding. 
 As previously mentioned, we found that changes in the 1H-15N HSQC spectra of 
Vt∆C are indicative of loss in structural relative to Vt, while Vt∆C5, which removes only the 
hydrophobic hairpin at the C-terminus of Vt, shows similar NMR spectra to wild-type Vt 
indicating similar fold.  As Vt∆C5 does not appear to perturb the tertiary fold of Vt and is 
postulated to play a role in membrane insertion, we conducted lipid co-sedimentation 
experiments with Vt∆C5.  We found that similar to Vt∆N, Vt∆C5 significantly increases 
association with PIP2 containing vesicles.  Interestingly, in the crystal structure of vinculin, 
Y1065 (removed in Vt∆C5) forms tertiary contacts with both D882 and S914 (which also 
appears to makes polar contact with D882), in the N-terminal strap and helix 1-2 loop, 
respectively, possibly linking the N and C-termini.  Thus, the apparent increase in PIP2 
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binding associated with the Vt∆C5 mutant may results from the release of the contacts with 
D882, allowing for increased release of the N-terminal strap from the helical bundle. 
 
D.  Discussion 
 The regulation of the actin cytoskeleton, its connections to the cell membrane, and the 
linkage to neighboring cells or extra cellular matrix all play an integral part in many 
physiological and pathological processes.  Cell processes including migration, differentiation, 
proliferation, and survival, along with larger scale processes such as tissue organization, 
wound healing, and tumorigenesis are all regulated in part by dynamic regulation of cell 
adhesions and the actin cytoskeleton[39-42].  Motility changes required for many of theses 
processes involves dynamic creation, stabilization, and turnover of sites of adhesion[43, 44], 
with vinculin playing an important role[5, 22, 23, 45, 46].  The activation and function of 
vinculin has been shown to be spatially and temporally regulated in cells, and vinculin has 
been associated with the strengthening of adhesions[47, 48].  Intriguingly, interactions with 
lipids play a role in the regulation of adhesion site turnover[22, 23].  The lipid binding 
function of vinculin is localized to the tail domain (Vt), which had been reported to bind to 
acidic phospholipids, including PS, PI, and PIP2[20, 21].  Of these, PIP2 is of particular 
interest as it is known to be an important regulator of the actin cytoskeleton[32].  As many of 
the reports of Vt lipid binding were in the context of pure lipid vesicles, we were interested in 
assessing binding in more physiological mixed lipid vesicles.  We found that Vt does not 
bind significantly to vesicles containing PE, PC, and PS, while demonstrating a significant 
concentration dependent binding to PIP2 containing vesicles (Figure 4.1).  Although Vt has 
been shown to bind pure PI and PS vesicles, we observed only minimal co-sedimentation 
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with mixed lipid vesicles containing PI or PS (Figure 4.2).  Local concentrations of PIP2 are 
controlled by both synthesis and sequestration, and regulated by signaling pathways known 
to affect the actin cytoskeleton such as the Rho and Rac families of GTPases[31].  The 
selective affinity of vinculin for PIP2 suggests this interaction may be a link in the regulation 
of actin cytoskeletal dynamics. 
 Our lipid co-sedimentation assays indicated that Vt exhibits marked affinity for PIP2, 
but does not specifically associate with vesicles containing PE, PC, and PS.  It is of interest 
to note that while vinculin does not appear to specifically bind phosphatidylcholine (PC), we 
see interactions with dodecylphosphocholine (DPC) micelles.  In fact our CD and NMR data 
support loss of tertiary structure and lipid specificity upon association with micelles (Figure 
4.3).  These observations suggest that Vt may interact with lipid micelles acting as a 
detergent to unfold Vt.  Therefore, micelles may not mimic physiological lipid interactions. 
 How PIP2 interacts with Vt to modulate vinculin function remains unclear.  Vinculin 
does not contain motifs known PIP2 binding motifs[30], and mutation and deletions reported 
to block lipid binding have not identified a clear site of binding[17, 19-23].  Supporting the 
observations of Saunders, et al [23], our data supports a loss in structural stability associated 
with the C-terminal deletion mutant Vt∆C (Figure 4.4).  Hence, loss of lipid binding may 
result from an altered tertiary structure.  In contrast, removal of the hydrophobic hairpin 
results in enhanced PIP2 association and does not appear to alter Vt structure.  Moreover, our 
results indicate that removal of the hydrophobic hairpin (TPWYQ) is not critical for lipid 
insertion, as previously proposed[19].  Removal of an additional two amino acids from the C-
terminus, Vt∆C7, causes spectral perturbations that may be indicative of a structural change, 
albeit not as extensive as those observed for Vt∆C (Figure 4.5).  These results indicate that 
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perturbations of contacts between the basic collar residues, R1060 and K1061, and both the 
bottom of helix 1 and the N-terminal strap, may alter Vt structure, which should be noted 
when interpreting the lipid binding data of Vt variants containing mutations at these 
positions. 
 Intriguingly, analysis of lipid binding data on multiple Vt mutants (Vt∆N, D882A, 
and H906A), indicates that perturbation of interactions with the N-terminal strap of Vt 
enhances PIP2 association (Figure 4.6 and 4.7).  It is possible that the release of this strap 
may expose a surface important for lipid binding, allowing for the formation of a lipid 
binding surface not present in the closed conformation, or more readily allow a 
conformational change required for lipid binding.  It is intriguing to speculate that residues in 
the basic collar (K911 and K924) become more accessible for interaction with PIP2 upon 
release of the N-terminal strap, as these residues have been proposed to be important for PIP2 
association[17, 23].  It has also been reported that a rearrangement in the N-terminal strap of 
Vt may be required for F-actin binding[49], and that  PIP2 inhibits interactions of vinculin 
with F-actin[36, 50].  Rearrangement of the N-terminal strap of Vt may be a common 
requirement for the binding of either PIP2 or F-actin, with both ligands sharing a mutually 
exclusive, overlapping site of interaction.  This would be consistent with the hypothesis that 
PIP2 binding may displace vinculin from F-actin, allowing focal adhesion turnover as has 
been proposed[22, 23].  
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Figure 4.1:  The lipid binding of wild-type Vt was examined by co-sedimentation studies 
with lipid vesicles containing 60% phosphatidylethanolamine (PE), 20% phosphatidylcholine 
(PC), and either 20% phosphatidylserine (PS) by weight or with phosphatidylinositol 4,5-
bisphosphate (PIP2) at concentrations that replace PS.  Soluble (S) and pellet (P) fractions 
were analyzed by SDS polyacrylamide gel electrophoresis (stained with coomassie), and a 
representative gel is shown in A.  Gels were scanned and the amount of protein in each 
fraction quantified using ImageJ software.  Wild-type Vt shows minimal binding to vesicles 
containing 60% PE, 20% PC and 20% PS (displayed as 0% PIP2), while exhibiting increasing 
association as PIP2 concentrations are increased (B), suggesting a specific affinity for PIP2. 
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Figure 4.2:  To compare the affinity of Vt for PS, PI, and PIP2, co-sedimentation studies 
with mixed lipid vesicles containing PE, PC, and either PS and PI.  Binding of PS and PI was 
minimal at concentrations up to 15%.  
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Figure 4.3:  The structural effect of association with dodecylphosphocholine (DPC) micelles 
was assessed by CD and NMR.  While the far UV CD of Vt in the presence of 100 mM DPC 
shows only minor alteration, the near UV CD is drastically reduced (A).  This is consistent 
with a minor change in secondary structure in Vt due to interactions with DPC, but a 
significant change in tertiary structure.  This is further supported by NMR studies.  1H-15N 
HSQC NMR spectra were collected on 0.15 mM Vt at pH 5.5, both alone and in the presence 
of 100 mM DPC (B).  The loss of spectral dispersion and the increase in resonances with 
chemical shifts close to the random coil values (~8.3 ppm) suggest that Vt losses significant 
tertiary structure upon association with DPC micelles.  As vinculin does not appear to 
specifically bind phosphatidylcholine (PC), interactions with dodecylphosphocholine (DPC) 
micelles are likely non-specific.  In addition, Vt showed similar structural perturbation with 
all lipid micelles tested, suggesting that lipid micelles may act as a detergent, unfolding Vt. 
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Figure 4.4:  The deletion mutant, Vt∆C, lacking the 15 C-terminal residues of Vt has been 
reported to be deficient in lipid binding.  In order to assess possible structural perturbations 
due to this deletion, we conducted NMR and CD studies of Vt∆C.  The 1H-15N spectrum of 
Vt∆C exhibits increased overlap resulting from a collapse in chemical shift dispersion and an 
increase of resonances with random coil chemical shifts (~8.3 ppm) (A).  This is consistent 
with a loss of structural stability due to the C-terminal deletion.  The far UV CD of Vt∆C 
shows minor changes relative to wild-type Vt (B), suggesting only small alterations in the 
overall helical content.        
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Figure 4.5:  To assess the role the hydrophobic hairpin and C-terminal basic collar residues 
in Vt structure, two deletion mutant (Vt∆C5 and Vt∆C7) were created.  Vt∆C5 removes only 
the hydrophobic hairpin (the final five C-terminal residues), while Vt∆C7 removes an 
additional two residues that are part of the basic collar (R1060 and K1061).  As seen in A, 
the 1H-15N HSQC spectra of Vt∆C5 is nearly identical to that of wild-type Vt, consistent with 
the deletion of the hydrophobic hairpin causing minimal changes to the structure of Vt.  In 
contrast, the 1H-15N HSQC spectra of Vt∆C7 shows exhibits changes similar to those seen in 
Vt∆C (Figure 4.4), although not as drastic.  The changes seen in the spectra of Vt∆C are 
consistent with the deletion of R1060 and K1061 causing a loss in tertiary stability, 
suggesting these residues play a role in the tertiary stability of Vt. 
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Figure 4.6:  The structure of Vt (from 1ST6), highlighting the interactions of the N-terminal 
strap of Vt with the helix 1-2 interface and the C-terminus.  The N-terminal strap of Vt is 
depicted in green, while the C-terminus is shown in yellow (with the hydrophobic hairpin 
shown in red).  Two significant residues (F885 and D882) of the strap make interactions 
likely to stabilize the extended conformation of the strap, which packs against the helix 1-2 
interface.  F885 of the N-terminal strap packs against H906 of helix 1, while D882 makes 
polar interactions with S914 (helix 1-2 loop), K924 (helix 2), and K1061 and Y1065 in the 
C-terminus. 
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Figure 4.7:  While wild-type Vt exhibits a PIP2 dependent association with lipid vesicles, a 
number of mutant forms of Vt show marked increase in PIP2 affinity.  Of these, Vt∆N, Vt 
D882A, and Vt H906A are all likely to allow for increased release of the N-terminal strap 
from its conformation packed along the helix 1-2 interface.  Both Vt∆N and Vt D882A 
remove D882, which makes polar interactions with residues in the helix 1-2 interface and the 
C-terminus.  Vt H906A should disrupt the packing of F885.  The increase in PIP2 binding 
seen with these mutants is consistent with the hypothesis that a conformational change in the 
N-terminal strap of Vt facilitates high affinity lipid binding.  Vt∆C5 also exhibits increased 
association with PIP2 containing vesicles, and either could also effect the conformation of the 
N-terminal strap (through loss of interactions with D882), or its removal may expose an 
occluded surface to allow lipid binding.  For details of the structural interactions of D882, 
F885, H906A, and residues in the helix 1-2 interface and the C-terminus, see Figure 4.6. 
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Chapter V. 
Conclusion 
 
A.  Introduction 
 Vinculin is a highly conserved and abundant cytoskeletal protein involved in linking 
the actin cytoskeleton to sites of adhesion[1].  Vinculin localizes to specialized multi-protein 
involved in various types of cellular adhesion, including adherence junctions (cell-cell 
adhesion), focal adhesions (cell-extracellular matrix adhesion), costameres (linkage between 
the force producing sacromeres and the cell membrane in muscle cells), and intercalated 
discs (specialized adhesions between adjacent cardiac cells)[1-4].  Vinculin is critical in 
development, as vinculin null mice die in early embryogenesis with heart and brain 
defects[5].  Vinculin has the properties of a tumor suppressor, and reduction in vinculin 
expression in cells results in increased motility, increases invasiveness, resistance to 
apoptosis and anoikis, and the ability to grow in soft agar[6-10].  In addition, transfection of 
vinculin cDNA into cancer cells lines causes a drastic suppression of tumorigenicity[11].  
Vinculin also plays a role in cardiovascular health, and both mutations or reduction in 
vinculin expression has been linked to cardiomyopathies in human patients[12-14]. 
 Vinculin is a 116 kDa protein consisting of three domains; a head domain (Vh), and 
flexible neck, and a tail domain (Vt).  Each vinculin binds a number of ligands, including 
talin, α-actinin, α-catenin, β-catenin, and the bacterial virulence factor IpaA for the head 
domain, vinexin, ponsin, the Arp 2/3 complex, and the vasodilator-stimulated phosphoprotein 
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(VASP) for the neck domain, and F-actin, paxillin, protein kinase C-α (PKCα), and acidic 
phospholipids for the tail domain[15].  In addition, the head and tail domain interact, forming 
a closed, auto-inhibited conformation which must be released in order to bind many 
important ligands, including F-actin, talin, α-actinin, VASP, PKCα, the Arp2/3 complex, and 
acidic phospholipids[16-22].   Current models of vinculin activation and function suggest a 
combinatorial activation mechanism requiring the interaction of ligand on both the head and 
tail domains, and that the activation of vinculin is regulated both spatially and temporally[15, 
23, 24].  Conformational changes in both the head and tail domain have also been proposed 
to play a critical role in vinculin function[25-33].  
 Despite significant research, both the physiological role and detail structural 
information about many of vinculin’s ligand interactions is still unclear.  Multiple proposed 
conformational changes in Vh and Vt are also not well understood.  In order to elucidate the 
role of vinculin in both physiological and pathological processes including, development, 
cancer, and cardiovascular health, a details understanding of vinculin activation, ligand 
binding, and conformational changes is required.  My doctoral dissertation has focused on 
increasing the understanding of conformation changes and ligand binding of the tail domain 
of vinculin.  I have addressed the following topics: 
 
• Backbone 1H, 13C, and 15N NMR Assignments of the Tail Domain of Vinculin 
• The Role of pH and Histidine 906 in Vinculin Tail Conformation 
•  Vinculin Tail and Lipid Binding 
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B.  Backbone 1H, 13C, and 15N NMR Assignments of the Tail Domain of Vinculin 
 
1.  Summary of Results 
 a)  The majority of the backbone 1HN, 15N, 13Cα, 13CO, and side chain 13Cβ NMR 
resonance assignments of the tail domain of vinculin were determined. 
 
2.  Implications 
 Multidimensional nuclear magnetic resonance (NMR) spectroscopy can provide atom 
specific probes of the electrochemical environment of proteins in solution.  This makes NMR 
uniquely suited to the study of protein structure, dynamics, and ligand binding.  However, a 
prerequisite of atom specific studies of proteins by NMR is the assignment of the observed 
resonances.  Assignment of the protein backbone NMR resonances provides residue specific 
probes sensitive to a variety of perturbations.  Changes in the chemical shift and/or intensity 
of a resonance are signs of changes in the electrochemical environment of the corresponding 
amino acid, and can represent changes in protein conformation, dynamics, or alterations due 
to ligand binding. 
 The majority of the backbone 1HN, 15N, 13Cα, 13CO, and side chain 13Cβ NMR 
resonance assignment were determine for wild-type Vt at pH 5.5.  Backbone amide proton 
assignments were extended to pH 7.5.  The NMR resonance assignments for the backbone of 
Vt has allowed the residue specific analysis of the effect of pH, both point and deletion 
mutations, and ligand binding on the structure and conformation of Vt. 
 
3.  Current and Future Directions 
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 The NMR resonance assignments of Vt, deposited in the Biological Magnetic 
Resonance Data Bank (BMRB), serve as a basis for current and future NMR studies of Vt.  
Current and future work in the Campbell lab that has and will benefit from the NMR 
resonance assignments of Vt may include: 
- Assessing perturbations in Vt resulting from mutagenesis 
- Mapping the site of interaction on Vt for the LD2 peptide of paxillin 
- Further characterization of the Vt self-association of Vt, and its effect on F-
actin bundling 
- Determining the site of interaction of actin on Vt  
In addition, as the assignments have been publicly deposited, they may also be used by 
additional research groups as a starting point for their own NMR studies of Vt. 
While the majority of the 1HN, 15N, 13Cα, 13CO, and side chain 13Cβ NMR resonance 
assignments of Vt have been determined, full backbone and side chain assignments has not 
been completed due to intrinsic difficulties with the system.  Vt self-association, dynamics, 
and conformational exchange may have all contributed to making complete assignments 
impractical.  If it is determined that further resonance assignments are required for future 
experiments, additional strategies could be used to determine additional assignments.  These 
strategies may include selective mutagenesis to decrease self-association and selective 
isotopic labeling to decrease spectral overlap and possible resonance assignments.  
Additionally, if the question about structural or dynamic properties of Vt arise, more 
complete assignments may be possible with Vt variants which decrease self-association. 
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C.  The Role of pH and Histidine 906 in Vinculin Tail Conformation 
 
1.  Summary of Results 
a)  Mutation of Histidine 906 to Alanine does not significantly alter Vt structure. 
b)  There is no significant conformational change in Vt between pH 5.5 and 7.5, and the 
effect of pH on Vt and the variant, Vt H906A, are virtually indistinguishable. 
c)  Vt self-associates at both pH 5.5 and 7.5, however the interaction is weak and may not be 
physiologically relevant. 
 
2.  Implications 
 The tail domain of vinculin was reported to undergo a H906-dependent 
conformational change as a function of pH and acidic phospholipid binding.  In addition, 
H906 was reported to be important for Vt self-association at low pH 5.5[33].  These results 
suggested that H906 and its protonation state may play an important role in Vt 
conformational changes, which could play a part in vinculin activation and function. 
In order to clarify the role of H906 in both pH and lipid dependent Vt conformational 
changes, we first assessed the effect of the histidine to alanine mutation at position 906 in Vt, 
as this variant, Vt H906A, was used in the studies implicating H906 in conformational 
changes in Vt[33].  We found no indication of a significant change in the overall 
conformation of Vt H906A, relative to wild-type Vt.  Circular dichroism spectra, both at both 
near and far ultraviolet wavelengths (350-250 nm and 260-190 nm respectively), show no 
significant difference between wild-type Vt and Vt H906A.  We also collected and compared 
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2 D 1H-15N Heteronuclear Single Quantum Coherence (HSQC) NMR spectra of wild-type Vt 
and Vt H906A.  Comparison of the chemical shift and intensity changes associated with the 
HN resonances, indicate that the mutation of H906 to alanine may cause localized 
perturbation in the N-terminal strap, but the overall conformation of the helical bundle is 
unaltered.  Although changes in HN resonances in HSQC spectra can not be conclusively 
interpreted in terms of specific changes in conformation, the spectral differences between 
wild-type Vt and Vt H906A are consistent with a change in the packing of the N-terminal 
strap of Vt.  In the crystal structure of vinculin, this N-terminal strap is packed along the 
helix 1-2 interface in an extended conformation[25].  F885 in the N-terminal strap packs 
against H906 (in helix 1), and disruption of this interaction would likely alter the packing of 
the strap.  Protonation of the H906 side chain could in theory disrupt the interaction with 
F885.  To test this possibility, we assessed pH dependent changes in both CD and NMR 
spectra of Vt and Vt H906A. 
In contradiction to the work of Miller et al, our data suggests that there is no 
significant conformational change in Vt between pH 5.5 and pH 7.5.  Moreover, the localized 
spectral changes as a function of pH observed by NMR are virtually identical for Vt and Vt 
H906A, indicating that H906 does not play a critical role in any significant pH dependent 
effects.  Furthermore, pH dependent chemical shift changes in the N-terminal strap and helix 
1 and 2 for both wild-type Vt and Vt H906A are small (less than 0.05 ppm on average).  This 
is consistent with the hypothesis that protonation of the side chain of H906, between pH 5.5 
and 7.5, does not cause a significant conformational change in the N-terminal strap. By 
comparison, the chemical shift changes between wild-type Vt and Vt H906A are more 
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substantial (up to 0.3 ppm), suggesting that mutation of H906 to alanine perturbs interactions 
with the N-terminal strap more so, than does the protonation of the H906 side chain. 
We also analyzed the self-association of both Vt and Vt H906A at pH 5.5 and 7.5.  
While Miller et al reported that Vt was monomeric at pH 7.5 but self-associated at low pH, 
we found that Vt self-association was present at both pH 5.5 and 7.5.  Sedimentation 
equilibrium analytical ultracentrifugation (AUC) indicated that Vt self-association is greater 
at pH 7.5 than pH 5.5, however the interaction is weak (Kd >100 µM) at both pH values.  
Given Kd’s determined by AUC, this self-association may not be physiologically significant.  
Vt H906A was also determined to self-associate at both pH 5.5 and 7.5, with a greater 
association at higher pH, as was observed with wild-type Vt.  While the Kd for Vt H906A 
self-association was 190 ± 30 µM relative to 130 ± 10 µM for wild-type Vt at pH 7.5, it is 
not clear if this difference is significant. 
 
3.  Current and Future Directions 
 Our data suggests that there are no significant pH dependent conformation changes in 
Vt, and therefore pH is not likely to play a role in the Vinculin activation or function.   With 
no link evident between ligand dependent conformational changes and pH, there is no data to 
suggest that pH changes over a physiologically relevant pH range play a role in modulating 
vinculin function, via either Vt-dependent ligand or self-association.  As such, without 
additional data to suggest a role for pH dependent functional changes, further study of pH 
effects on Vt is not warranted.  There are two remaining points of interest in this research; 
release of the N-terminal strap, and Vt self-association. 
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 NMR spectral comparison of wild-type Vt and VtH906A HN resonances suggest that 
there is no significant alteration in the main helical bundle due to mutation of histidine 906 to 
alanine.  There is, however, evidence to suggest that that the N-terminal strap may be altered 
due to loss of the interaction between H906 (in helix 1) and F885 (in the strap).  This 
alteration in the N-terminal strap due to mutation of H906 is of particular interest as it 
appears to play a role in Vt/ligand interactions.  In particular, Vt H906A and other mutant 
forms of Vt that appear to perturb interactions between the N-terminal strap and the helix 1-2 
interface enhance Vt-PIP2 association (see Chapter 4).  Further characterization of the 
alterations in the N-terminal strap of these mutants (including H906A) may elucidate binding 
determinants and/or conformational changes associated with phospholipid binding.  In 
addition, the N-terminal strap of Vt has been suggested to change conformation to 
accommodate F-actin binding, and possibly play a role in F-actin bundling[31].  The mutant 
characterized in these studies, Vt H906A, may be useful in elucidating the role of the N-
terminal strap of Vt in F-actin binding and bundling. 
 We found that the Vt self-association occurs at both pH 5.5 and pH 7.5, with a small 
increase in affinity at pH 7.5.  This is in contrast to previous work suggesting that that Vt 
self-association only at the lower pH[33].  The degree of self-association at either pH is weak 
(Kd > 100 µM).  Despite the significant levels of vinculin found in cells and the possibility of 
increased localized concentration, this weak self-association may not be able to compete with 
other ligand interactions that may bind with higher affinity.  For example, the Vh-Vt 
interaction has an estimated Kd of ~1 nM[25], and may inhibit Vt self-association.  With the 
Kd of self-association >100 µM, this interaction may not be physiological relevant unless it is 
modulated by the binding of additional ligands.  Self-association of Vt in the presence of 
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ligands is thought to be physiologically important.  Vt has been reported to self-associate in 
the presence of both actin and phospholipids, with Vt dimerization postulated to be critical 
for F-actin bundling[31, 32, 34].  However, it is unclear whether the self-association 
observed in solution in the absence of ligands, is related to or distinct from ligand induced Vt 
self-association.  The Vt dimer that promotes F-actin bundling may be either 1) a separate, 
cryptic site of self-association not accessible in the conformation present in solution, or 2) an 
allosteric enhancement of the ligand-free self-association site.   Characterization of the 
ligand-free self-association observed in solution by NMR has suggested that the site of 
interaction is similar to the dimer interface identified in the crystal structure of Vt[26].  
Characterization of mutations designed to disrupt this ligand-free self-association is 
underway, and these mutants may aid in understanding the role of Vt dimerization in F-actin 
binding and bundling. 
 
D.  Vinculin Tail and Lipid Binding 
 
1.  Summary of Results 
a)  Vt shows little affinity for mixed lipid vesicles containing 20% phosphatidylserine 
b)  A concentration dependent co-sedimentation of Vt with PIP2 containing vesicles indicates 
specific recognition of PIP2. 
c)  Although Vt has been reported to bind pure phosphatidylinositol (PI) vesicles, we find 
that that the affinity for PI containing vesicles is significantly reduced compared to PIP2. 
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d)  Vt demonstrates a loss of tertiary structure and lipid specificity in the presence of 
micelles, suggesting Vt interactions with micelles do not mimic physiological lipid 
interactions. 
e)  The C-terminal deletion mutant, Vt∆C, shows a loss of tertiary structure, which may 
contribute to its loss of lipid binding.  In addition to W1058 (proposed to be C-terminal 
residue important for tertiary structure[35]), R1060 and K1061 also appear important for 
maintaining the structural integrity of the Vt helical bundle fold. 
f)  The “hydrophobic hairpin” (TPWYQ) at the extreme C-terminus does not appear to be 
important for lipid insertion as previously proposed[26]. 
g)  Release of the N-terminal strap of Vt facilitates higher affinity interactions with PIP2 
containing vesicles. 
 
2.  Implications 
 The tail domain of vinculin has been reported to bind acidic phospholipids, including 
phosphatidylserine (PS), phosphatidylinositol (PI), and phosphatidylinositol 4,5-bisphosphate 
(PIP2)[18, 25, 26, 36].  Methods used to assess phospholipid binding have varied 
significantly, making comparative literature studies of Vt and mutant Vt lipid binding 
profiles difficult.  We demonstrated that Vt exhibits minimal binding to mixed lipid vesicles 
containing 60% phosphatidylethanolamine (PE), 20% phosphatidylcholine (PC), and 20% 
phosphatidylserine (PS).  The major components of eukaryotic membrane are PC, PE, PS, 
and PI[37].  Previous demonstrations of PS binding utilized pure PS vesicles, however PS is 
generally believed to constitute only 5-10% of the plasma membrane[37, 38].  The lack of Vt 
binding to mixed vesicles containing 20% PS suggests that the binding of PS may not 
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physiologically significant.  In contrast, we demonstrated that Vt associates with mixed lipid 
vesicles in a PIP2 concentration dependent manner, with significant association at 15% PIP2.  
Although PIP2 is a minor constituent of plasma membranes (0.1-5%), it is known to be 
enriched in focal adhesion[39, 40], and is known to directly regulate the actin cytoskeleton 
through modulating the activation and localization of cytoskeletal and regulatory 
proteins[41].  The specific affinity of Vt for PIP2 suggests that this interaction may play a 
physiological role at sites of adhesion.  One proposed function of the Vt-PIP2 interaction is in 
the turnover of focal adhesions, a process critical to cellular motility. 
 Micelles have been used in studies of Vt lipid binding, however our data suggests that 
Vt interaction with micelles may not be physiologically relevant.  In addition to a significant 
loss of tertiary structure upon interaction with micelles, Vt appears to loose all lipid 
specificity.  Thus, lipid micelles may act as a detergent, unfolding Vt, and caution should be 
taking in interpreting reports of Vt-lipid binding based on methods utilizing lipid micelles.  
 As has been suggested previously, we found evidence that the C-terminal deletion 
mutant, Vt∆C, exhibits a loss in tertiary structure and stability. Thus, the decrease in 
phospholipid binding observed with this mutant may be due to a loss in tertiary structure, 
rather than disruption of specific phospholipid interactions with the C-terminus.  Moreover, 
the proposed role of the hydrophobic hairpin in membrane insertion (based on studies of 
Vt∆C), does not appear to be correct.  We demonstrated that the removal of the hydrophobic 
hairpin (Vt∆C5) likely has minimal effects on the structure or conformation of Vt, while lipid 
binding is actually increased.  These results suggest that insertion of the hydrophobic hairpin 
into lipid membranes is not a critical factor in lipid binding. 
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 In addition to the hydrophobic hairpin in the C-terminus of Vt, two basic surfaces 
have been proposed as site of lipid interaction; the basic collar and the basic ladder[25, 26, 
28].  Distinct from these two sites, we have identified the N-terminal strap of Vt as an 
important element in phospholipid binding.  Our evidence indicates that the release of the 
strap from its interaction with the helix 1-2 interface enhances lipid binding, suggesting that a 
conformational change in the N-terminal strap of Vt may play a role in vinculin function.  
Although residues responsible for PIP2 binding and specificity have not yet been 
conclusively identified, release of the strap may possibly increase the accessibility of K911 
and K924, both residues postulated to be important for lipid binding[25, 35].  Interestingly, 
multiple ligand interaction sites, including those of vinexin, ponsin, and the Arp 2/3 complex, 
have been identified in the flexible neck region of vinculin, directly proceeding the strap of 
Vt[15].  The binding of ligand to the neck region of vinculin could affect the N-terminal strap 
of Vt, facilitation lipid binding, or conversely, Vt-lipid interaction could also cause a 
conformational change in the strap, facilitating ligand binding to the neck of vinculin. 
 
3.  Current and Future Directions 
 Although we have identified the N-terminal strap of Vt as an important factor in lipid 
binding, the mode and exact site of lipid interaction is still unclear.  Multiple mutations have 
been identified that increase lipid binding, however Vt mutations which disrupt lipid binding, 
without significantly alter Vt structure, have not been identified.  Basic collar residues and 
residues which would likely be exposed by release of the N-terminal strap of Vt can be 
mutated, and the effects of such mutations assessed.  These residues may include R910, 
K911, and K924.  Further complicating Vt lipid binding, it has been proposed that Vt may 
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undergo a significant conformational change upon interaction with lipids.  Although we do 
not believe that the loss of tertiary structure seen upon interactions with lipid micelles is 
physiological, we have not been able to assess effects of interactions with lipid vesicles on 
the structure of Vt.  If Vt undergoes a significant conformational change upon lipid binding, 
the site of PIP2 interaction may not present in the crystal structure, complicating its 
identification.  One method of assessing changes in the conformation of Vt upon lipid 
binding is the comparison of Vt’s protease sensitivity in the presence or absence of lipid 
vesicles.  Changes in the extent, or pattern of protease digestion could indicate whether a 
conformational change occurs upon phospholipid binding.  In addition, mass spectrometry 
may aid in identification of sites of altered cleavage, which could indicate regions of Vt 
undergoing conformational changes. 
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